What`s inside
Transcription
What`s inside
Final 12th-14th January, 2012 - Singapore What's inside... . The Course programme . Exhibition plan . General information . Exclusive interviews Board of Directors, Scientific Committee Members & Plan Course Directors Tian-Hai Koh Eric Eeckhout Singapore Switzerland Programme Committee Members Takashi Akasaka Jun-Jack Cheng Japan Taiwan Do Quang Huan Myeong-Ki Hong Vietnam South Korea Rosli Mohd Ali Sunarya Soerianata Malaysia Indonesia Course Co-Directors Terrance Chua Jean Fajadet Singapore France Junbo Ge Soo-Teik Lim China Singapore Marie-Claude Morice Christoph Naber France Germany Shigeru Saito Patrick W. Serruys Japan Netherlands Aaron Wong Singapore Chairman of PCR Jean Marco Bien Soo Tan France Singapore Plan Interactive Case Corner Room 2 Room 3 Room 206 Room 205 Room 207 Room 204 Training Village Exhibition Hall Exhibition Hall Room 208 Room 203 Room 209 Main Arena Preview Room Room 201 Posters Gallery Main Entrance Entrance ZONE 1 ZONE 2 DAY PASS AND FULL PASS ACCESS ONLY ALL TYPES OF BADGES 1 Final Programme / 12th-14th January, 2012 / Singapore Editorials Dear Friends, It gives us great pleasure to welcome all of you to AsiaPCR/SingLIVE 2012. AsiaPCR/SingLIVE is created with the fundamental building blocks: patient-centred, innovative session formats, open-mindedness, interactivity, continuous evaluation and improvement. Through the exchange of views and experience among healthcare professionals, we hope to contribute to the advancement of cardiovascular care, particularly in Asia. The 2011 edition saw more than 1,700 attendees from 56 countries, an 11% increase on 2010. Building upon the success of 2011, we have weaved more case discussions into the programme, with live demonstrations, adequate time for discussion and an even higher level of interactivity. For the 3rd AsiaPCR/SingLIVE, we have lined up core topics on coronary, structural heart, endovascular/peripheral, imaging as well as a nurse,technician & radiographer forum. The structural heart segment will showcase recent developments in the exciting and emerging field of disease therapies. Experts in the field will review state-of-the-art treatment for aortic stenosis, transseptal puncture, mitral regurgitation, left atrial appendage closure and ASD/PFO, amongst other exciting topics. The advent of these new minimally invasive techniques allow the modern Tian-Hai Koh AsiaPCR/SingLIVE Course Director National Heart Centre Singapore, Singapore PCR Family is an organisation dedicated to education and information in the field of cardiovascular therapies, most notably for cardiovascular intervention and interventional medicine. Our motto is “innovation in education at work” Our aim is to help the community to respond to the fundamental question that impacts the daily practice of every cardiologist: “What is the best management and technical strategy for each patient presenting with a specific cardiac disease, given his clinical situation, in the light of local experience and best available evidence?” PCR Family is not to be considered as a model. None of the numerous educational practices can constitute a strict model since each country and region have their own particularities. Education in PCR activities is based on sharing knowledge and experience. Our courses are made “by and for” local participants as well as those from abroad. We would like you to consider yourself as simultaneously the source, the inspiration and the target of the educational content. interventionalist to offer a wide range of therapeutic modalities that were mainly unheard of just a decade ago. A new area of focus will be on hypertension management using radiofrequency renal denervation. This is an exciting treatment option that will expand the repertoire of the cardiovascular interventionalist. We have incorporated the nurses and technician forum into this year’s programme. This permits our nursing and paramedical colleagues to learn the technical aspects of device preparation, anticipate technical issues and manage complications. Live transmissions remain an integral element of the course with Asian satellite transmission sites from China, India, Indonesia and Singapore. AsiaPCR/SingLIVE 2012 presents an excellent opportunity for a meeting of minds, making new acquaintances and renewing old ties. Do also make time to visit our dynamic city with a harmonious blend of culture, cuisine, arts and architecture - a uniquely Singapore experience. Welcome once again and we hope you will have an enjoyable time and an enriching learning experience here at AsiaPCR/SingLIVE. Eric Eeckhout AsiaPCR/SingLIVE Course Director Centre Hospitalier Vaudois, Lausanne, Switzerland If the cardiovascular community of Asia-Pacific region wishes to benefit from the knowledge and experience of PCR Family in education, it will be an honor for us. Our will is to share: together we can achieve more and build a new model of education that will benefit everyone, worldwide. During AsiaPCR/SingLIVE, we would like you to become active participants: express your concerns and issues, which are also experienced by many others. This will bring a major benefit to the whole cardiovascular community. We strive to deliver information with a balanced and constructive spirit, free from any external influence. Thank you for participating in AsiaPCR/SingLIVE. Prof. Jean Marco Chairman of PCR Final Programme / 12th-14th January, 2012 / Singapore 2 Live demonstrations programme See Live demonstrations from 5 centres National Heart Centre Medanta Medicity Singapore Gurgaon, India Thursday 12th Main Arena PCI in patients with complex left main disease in 2012 and beyond 08:40-09:30: Jean Fajadet - France Soo Teik Lim - Singapore Complex PCI in patients with difficult subsets in 2012 and beyond 14:30-15:15: Kay Woon Ho - Singapore Aaron Wong- Singapore Takashi Akasaka - Japan Friday 13th Main Arena Left main trunk and bifurcation - basics to practices Lunch symposium with an unrestricted educational grant from Terumo 12:40-13:25: Satoru Sumitsuji - Japan PCI in patients with complex bifurcation lesion in 2012 and beyond 15:55-16:40: Stanley Chia - Singapore Tian Hai Koh - Singapore Saturday 14th Thursday 12th Main Arena PCI in patients with complex left main disease in 2012 and beyond 11:05-11:50: Praveen Chandra - India Complex PCI in patients with difficult subsets in 2012 and beyond 16:20-17:05: Praveen Chandra - India Apollo Hospitals Hyderabad, India Thursday 12th Room 2 Drug-eluting balloons - a viable alternative in PCI Dinner symposium with an unrestricted educational grant from Eurocor 18:25-19:00: J. Shivkumar - India Main Arena Non-coronary transcatheter interventions in 2012 ▸ on TAVI 08:35-09:20: Paul Chiam - Singapore Eberhard Grube - Germany Chung-Yin Lee - Singapore Shanghai Institute of Cardiovascular Diseases Shanghai, China ▸ on renal denervation 10:20-11:05: Chee Tang Chin - Singapore Sharad Shetty - Australia Friday 13th ▸ on ASD 11:50-12:20: Eric Eeckhout - Switzerland Ju Le Tan - Singapore Saturday 14th Main Arena PCI in patients with high-risk acute coronary syndrome in 2012 and beyond 08:35-09:20 & 10:25-11:10: Jun Bo Ge - China Room 2 Coronary chronic total occlusion 08:30-09:20: Etsuo Tsuchikane - Japan Khung Keong Yeo - Singapore 10:30-11:20: Rohit Khurana - Singapore Masahiko Ochiai - Japan Harapan Kita Jakarta, Indonesia Friday 13th Main Arena PCI in patients with complex bifurcation lesion in 2012 and beyond 14:05-14:50 & 17:10-17:55: Sunarya Soerianata - Indonesia Jean Fajadet - France 3 Final Programme / 12th-14th January, 2012 / Singapore Session formats Session formats NEW Perspectives on "Call for" based sessions This new session format is a mini debate based on short lectures on a given topic, compiled from doctors practicing in different parts of the world. The physicians will consider challenging topics from their own personal perspective. Speakers from different origins will be requested to reflect on recent publications and share with the audience how it could be applied in their daily practice, in their institute, region, country… Join one of the sessions based on submissions: - Abstracts - Clinical cases & complications To discover educational cases encountered by your peers or explore the broad range of subjects addressed by the presentations. How should I treat? Interactive sessions with experts who will discuss complex cases of high educational value. They will provide practical approaches and solutions to problems and unusual situations encountered during PCI. Based on a concept from EuroIntervention Journal, a challenging case is presented to two experts who share their opinions on treatment and patient management. LTT (Learning The Techniques) An innovative and interactive concept combining the pedagogical skills of experienced practitioners and input from younger practitioners. These sessions are based on a step-by-step decision making process. Meet the experts Symposium Symposia aim to develop themes and present a clear synthesis of studies and trials. These industry supported sessions will allow you to integrate practical solutions to patient problems through knowledge and judgement. Final Programme / 12th-14th January, 2012 / Singapore 4 Faculty list - Valid as of 28/12/2011 Our sincere thanks to the Guest Faculty Their unique points of view are shaped by local cultures and constraints that helped us discover new ways of thinking. The excellent quality of the sessions was assured by the rich diversity of their backgrounds and the breadth of their expertise. Last name AGARWAL AHMED AHN AKASAKA AL SHAFI MAJUMDER ANG ANGIOI AZEEMUDDIN BERLAND BIRKEMEYER BUCHANAN BUDDHARI BUENDIA BURGMANS CHAE CHAN CHAN CHAN CHANDRA CHANDRA CHAO CHEAH CHEN CHEN CHEN CHENG CHEVALIER CHIA CHIAM CHIN CHNG CHONG CHOO CHOPRA CHOU CHUA CHUA CHUA CHUA COLOMBO CUISSET DESAI DEVLIN DHAKAM DING DO DO DUCROCQ DUDEK EECKHOUT ERGLIS ESCANED EWE FAJADET FUNG GAMBHIR GAO First name Country Praveer Tamzeed Taehoon Takashi Abdullah Cheng-Ho, Patrick Michael Muhammad Jacques Ralf Gill Louise Wacin Siro Mark In-Ho Kam-Tim Choong Meng Charles Subash Praveen Tar Toong, Victor Foong-Koon Shao-Liang Ji-Lin Matt Jun-Jack Bernard Stanley Paul Chee Tang Siew-Ping Yoon Sin Maurice Arun Chia-Yu Yeow-Leng Siang-Jin, Terrance Gim Chuah Benjamin Antonio Thomas Devang Gerard Sajid Zee-Pin Quang Huan Dai-Do Gregory Dariusz Eric Andrejs Javier See-Hooi Jean Chi-Yan Raymond Daljeet S. Runlin INDIA BANGLADESH SOUTH KOREA JAPAN BANGLADESH BRUNEI DARUSSALAM FRANCE PAKISTAN FRANCE GERMANY ITALY THAILAND SPAIN SINGAPORE SOUTH KOREA HONG KONG SINGAPORE SINGAPORE INDIA INDIA SINGAPORE SINGAPORE CHINA CHINA TAIWAN TAIWAN FRANCE SINGAPORE SINGAPORE SINGAPORE SINGAPORE MALAYSIA SINGAPORE INDIA TAIWAN SINGAPORE SINGAPORE SINGAPORE SINGAPORE ITALY FRANCE INDIA NEW ZEALAND PAKISTAN SINGAPORE VIETNAM SWITZERLAND FRANCE POLAND SWITZERLAND LATVIA SPAIN SINGAPORE FRANCE HONG KONG INDIA CHINA 5 Final Programme / 12th-14th January, 2012 / Singapore Last name GARCIA DEL BLANCO GARG GE GHANI GNANARAJ GOGNA GOH GOH GOTABHAYA GRUBE GUNASEGARAN GUO GWON HAN HANIF HIREMATH HO HO HSIEH INOUE IRANI JAFARY JANG KAPOOR KAR KARJALAINEN KAUL KENG KHAN KHURANA KLEBER KOH KONGPHANICH KOYAMA KRUCOFF KUM KWOK KWOK KYAW KYAW LAM LAM LAM LAU LEE LEE LEE LEE LI LIM LIM LIM LIU LO LOW LOW LOW First name Country Bruno Scot Jun Bo Rohaizah Binti Abdul Anand Apoorva Yu-Tang, Peter Ping-Ping Ranasinghe Eberhard Kurugulasigamoney Wen-Yi Hyeon-Cheol Ya-Ling Bashir Shirish M. S. Kheng Thye Kay-Woon I-Chang Naoto Farah Fahim H. Yang-Soo Rajneesh Saibal Pasi Upendra Yung-Jih, Felix Amol Rohit Franz Tian-Hai Chutcharn Yutaka Mitchell W. Steven Veronica Robert Soe-Win Zaya Kai-Huat Leslie Yat Yin Te-Neng Michael Kang-Yin Chung-Yin Stephen W. L. Ronald Chi-Hang Steven Siu-Lung Soo Teik Yean-Teng Michael Eugene Tsz-Ho, Sidney Adrian Reginald I. Shoen Choon Seng SPAIN UNITED KINGDOM CHINA MALAYSIA INDIA SINGAPORE SINGAPORE SINGAPORE SRI LANKA GERMANY SINGAPORE CHINA SOUTH KOREA CHINA PAKISTAN INDIA SINGAPORE SINGAPORE TAIWAN JAPAN SINGAPORE SINGAPORE SOUTH KOREA INDIA UNITED STATES FINLAND INDIA SINGAPORE INDIA SINGAPORE GERMANY SINGAPORE THAILAND JAPAN UNITED STATES SINGAPORE SINGAPORE SINGAPORE MYANMAR MYANMAR MALAYSIA SINGAPORE HONG KONG SINGAPORE HONG KONG SINGAPORE HONG KONG SINGAPORE HONG KONG SINGAPORE SINGAPORE SINGAPORE SINGAPORE AUSTRALIA SINGAPORE UNITED STATES SINGAPORE Faculty list - Valid as of 28/12/2011 Last name LUKITO MALIK MANOHARAN MARCO MASKON MATSUBARA MAURI MEHTA MEHTA MEREDITH MITHRAKUMAR MOHD ALI MOMENUZZAMAN MORICE MULLER MUNAWAR MURAMATSU MUTHUSAMY NABER NAKAMURA NAKAMURA NAKAZAWA NG NG NG NGUYEN NGUYEN NGUYEN OCHIAI OIKAWA ONG ONG ONG ONG PATEL PATHAN PHAM PIETILÄ POH PUA PUNAMIYA RADKE RAHMAN RAJAN RIFQI ROBLESS ROSLI ROSMAN SAKHOV SANTOSO SENARATNE SENEVIRATNE SENGOTTUVELU SERRUYS SETH SETHI SHETTY First name Country Antonia Anna Fazila Ganesh Jean Oteh Tetsuo Fina Ashwin Haresh Ian T. Sinnathuraj Sheikh Abdul Kader N. A. M. Marie-Claude Olivier Muhammad Toshiya Tamil Christoph K. Masato Sunao Gaku Swee-Choon Richard Keng Sin Lan Hieu Quang-Tuan Ngoc-Quang Masahiko Yuji Andrew Paul Tiong Kiam Hean-Yee Tejas Madhusadan Asad Manh-Hung Mikko Kian-Keong Uei Sundeep Peter Afzalur Dheeraj Sodiqur Peter Mohd Ali Azhari Orazbek Teguh Vajira Sujith G. Patrick W. Ashok Rajiv Sharad INDONESIA BANGLADESH UNITED KINGDOM FRANCE MALAYSIA JAPAN SPAIN INDIA INDIA AUSTRALIA SRI LANKA MALAYSIA BANGLADESH FRANCE SWITZERLAND INDONESIA JAPAN MALAYSIA GERMANY JAPAN JAPAN JAPAN MALAYSIA SINGAPORE SINGAPORE VIETNAM VIETNAM VIETNAM JAPAN JAPAN AUSTRALIA SINGAPORE MALAYSIA SINGAPORE INDIA PAKISTAN VIETNAM FINLAND SINGAPORE SINGAPORE SINGAPORE GERMANY BANGLADESH CANADA INDONESIA SINGAPORE MALAYSIA MALAYSIA KAZAKHSTAN INDONESIA SRI LANKA AUSTRALIA INDIA NETHERLANDS INDIA INDIA AUSTRALIA Last name First name Country SHIVKUMAR J. INDIA SIDIPRATOMO Prijo INDONESIA SIM Kui-Hian MALAYSIA SIN Yoong-Kong, Kenny SINGAPORE SITANBAOLI Biegelan KAZAKHSTAN SOERIANATA Sunarya INDONESIA SPANGER Manfred AUSTRALIA SRINIVASA K. H. INDIA SRIRAM Narayanan SINGAPORE SUMITSUJI Satoru JAPAN SURYAPRANATA Harry NETHERLANDS TAN Jack SINGAPORE TAN Ju Le SINGAPORE TAN Huay Cheem SINGAPORE TAN Swee-Yaw SINGAPORE TAN Ru-San SINGAPORE TAN Bien-Soo SINGAPORE TANEJA Manish SINGAPORE TANG Alex MALAYSIA TANGCO Rogelio PHILIPPINES TAY Edgar SINGAPORE TAY Kiang Hiong SINGAPORE TEDJOKUSUMO Pintoko INDONESIA TEO Swee Guan SINGAPORE TEO Wee-Siong SINGAPORE THACHATHODIYL Rajesh INDIA THOMAS Martyn UNITED KINGDOM TING Peter SINGAPORE TRESUKOSOL Damras THAILAND TRISNOHADI Hanafi INDONESIA TSUCHIKANE Etsuo JAPAN UDAYACHALERM Wasan THAILAND UDDIN Mir Jamal BANGLADESH VARENNE Olivier FRANCE VERHEYE Stefan BELGIUM WALTERS Darren AUSTRALIA WAN AZMAN Wan Ahmad MALAYSIA WESSELY Rainer GERMANY WONG Aaron SINGAPORE WONG Philip SINGAPORE WONG Daniel SINGAPORE WONGPRAPARUT Nattawut THAILAND WU Chiung-Jen TAIWAN YAHYA Achmad Fauzy INDONESIA YAMASHITA Takehiro JAPAN YAMIN Muhammad INDONESIA YAN Peter SINGAPORE YEO Khung Keong SINGAPORE YEOW Tow-Non SINGAPORE YIP James SINGAPORE YONG Quek-Wei SINGAPORE YOSHIMACHI Fuminobu JAPAN YUNIADI Yoga INDONESIA ZAMBAHARI Robaayah MALAYSIA ZHANG Bin CHINA Final Programme / 12th-14th January, 2012 / Singapore 6 Posters Gallery Visit the Posters Gallery We would like to thank all those who submitted an abstract this year. From the 89 submissions, we are pleased to list the abstracts selected for display in the Posters Gallery. Make sure you reserve some time to browse the Gallery. Visit the Posters Gallery and participate in the moderated discussions: > Thursday 12th: 16:30 - 17:30 with Eric Eeckhout and Aaron Wong > Friday 13th: 9:00 - 10:00 with Wan Ahmad Wan Azman and Philip Wong > Friday 13th: 15:00 - 16:00 with Fina Mauri and Andrew Ong ID01 ID11 SHETA M.K., Al-Azhar university, CAIRO, EGYPT LI X., LI T., FU N., HU Y., CONG H. Tianjin Chest Hospital, TIANJIN, CHINA Correlation between cTCD and cTEE for detection of right to left shunt in patients with cerebrovascular stroke ID02 A randomised comparison of Sirolimus-eluting stent implantation with Zotaromlimus-eluting stent implantation for the treatment of total coronary occlusions: one-year clinical and eight-month angiographic outcome of the PRISON III trial A meta-analysis about Angiotensin-converting enzyme Inhibitor' effect on contrast-induced nephropathy ID12 Atorvastatin combining with probucol can reduce serum uric acid level during perioperative period of intervention SUTTORP M.J., St Antonius Hospital, NIEUWEGEIN, NETHERLANDS LI X., WANG Y., LI Z., ZHANG Y., XIAO J., ZHAO R., CONG H. Tianjin Chest Hospital, TIANJIN, CHINA ID03 ID13 Radial artery patency post percutaneous coronary intervention with intravenous Enoxaparin as procedural anticoagulant WONG C.P., HO H.H., TAN J., LOH J.K., OOI Y.W., JAFARY F.H., FOO D., ONG P.J. Tan Tock Seng Hospital, SINGAPORE, SINGAPORE ID04 Long-term outcomes of percutaneous therapy for true bifurcation lesions treated with drug-eluting stents using the 'Shunt' technique Evaluation of SYNTAX score for unprotected left main coronary disease HORI M., IIJIMA R., NAKAMURA M. Toho university Ohashi medical center, TOKYO, JAPAN ID14 Single centre experience and outcome of primary PCI for STEMI without on-site surgical back-up SHETTY P.C., Wollongong Hospital, HORSLEY, AUSTRALIA SHETTY P.C. Wollongong Hospital, HORSLEY, AUSTRALIA ID05 ID15 SHETTY P.C., Wollongong Hospital, HORSLEY, AUSTRALIA ORABY M., NASR G., HAWARY A., SABAH M. Suez canal medical school, ISMAILIA, EGYPT ID06 ID16 FRIEDRICH G.(1), BONAROS N.(1), SCHACHNER T.(1), GRIMM M.(1), PACHINGER O.(1), BONATTI J.(2) (1) Medical University Innsbruck, INNSBRUCK, AUSTRIA ; (2) University of Maryland, BALTIMORE, UNITED STATES LIN G.M. Hualien-Armed Forces General Hospital, HUALIEN, TAIWAN Long-term outcome of patients who underwent percutaneous coronary interventions (PCI) for stable and unstable acute coronary syndromes, including STEMI, in a regional hospital without on-site surgical back-up Evaluation of cardiac and cerebrovascular events in robotic coronary bypass surgery and hybrid revascularisation procedures Safety and feasibility of transradial versus transfemoral approaches for diagnostic coronary angiography during early phase of the learning curve Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty ID17 ID07 Road to heart via hand. Trans-radial arterial and upper extremity venous access for cardiac catheterisation - the safety and feasibility study Risk factors and risk score for prediction of contrast induced nephropathy in patients undergoing percutaneous coronary intervention SURYAWANSHI S. Wockhardt Hospitals, Nashik, Maharashtra,India, NASHIK, INDIA FU N., LI X., YANG S., XU J., CHEN Y., CONG H. Tianjin Chest Hospital, TIANJIN, CHINA ID18 ID08 Angiographic and procedural outcomes of percutaneous coronary intervention in patients with chronic coronary artery occlusion after intracoronary adenosine administration PETRENKO I.(1), POPOVA M.(2), GORKOV A.(1) (1) Institution KHMAO «District cardiologic clinic «Center for Diagnosis and Cardiovascular Surgery»,, SURGUT, RUSSIAN FEDERATION ; (2) Surgut State University, SURGUT, RUSSIAN FEDERATION ID09 Efficacy of hydration with normal saline versus hydration with sodium bicarbonate in the prevention of CIN ILKHCHOOYI F., SOHRABI B. Madani Haert Hospital, TABRIZ, IRAN ID19 Trans-radial versus trans-femoral intervention for the treatment of coronary bifurcations: result from the the COBIS (COronary BIfurcation Stenting) registry CHUNG S., SONG P.S., CHOI S.H. Samsung Medical Center, Sungkyunkwan University School of Medicine, SEOUL, SOUTH KOREA Angiographic and procedural outcomes percutaneous coronary intervention of patients with diabetes mellitus type 2 and chronic coronary artery occlusion after intracoronary administration adenosine ID20 PETRENKO I.(1), POPOVA M.(2), PETRENKO O.(1) (1) Institution KHMAO «District cardiologic clinic «Center for Diagnosis and Cardiovascular Surgery»,, SURGUT, RUSSIAN FEDERATION ; (2) Surgut State University, SURGUT, RUSSIAN FEDERATION HUANG H.L. Tzu-Chi Buddhist General Hospital,Taipei Branch, NEW TAIPEI CITY, TAIWAN ID10 Optimisation contractile function of left ventricle patients with chronic coronary artery occlusion after intracoronary administration adenosine PETRENKO I.(1), POPOVA M.(2) (1) Institution KHMAO «District cardiologic clinic «Center for Diagnosis and Cardiovascular Surgery», SURGUT, RUSSIAN FEDERATION ; (2) Surgut State University Surgut, KhantyMansy autonomic okrug-Yugra/ Russain Federation, SURGUT, RUSSIAN FEDERATION Intensive survelliance followed by assisted intervention sustained long-term outcomes in patients with critical limb ischemia ID21 Incorporation of balloon-cushion stenting technique in left main coronary artery bifurcation intervention KU P.M. Chi-Mei Medical Center, TAINAN, TAIWAN Final Programme / 12th-14th January, 2012 / Singapore 8 Posters Gallery ID22 Late clinical impact of postprocedural incomplete stent apposition and late acquired incomplete stent apposition after deployment of Zotarolimus eluting stent or Everolimus eluting stent LEE S.R.(1), PARK J.(2), HONG Y.(3), RHEW J.(2), CHAE J.(1) (1) Chonbuk National University Hospital, JEONJU, KOREA, REPUBLIC OF (SOUTH KOREA) ; (2) Presbyterian Medical Center, JEONJU, KOREA, REPUBLIC OF (SOUTH KOREA) ; (3) Chonnam National University Hospital, GWANGJU, KOREA, REPUBLIC OF (SOUTH KOREA) ID23 Pulse pressure predict coronary calcification better than other BP parameters in Women-WECAC (Women & Coronary Artery Calcium) study LUKITO A.A. Siloam hospital Lippo Village, TANGERANG, INDONESIA ID24 Systolic blood pressure correlates to coronary calcification severity in women - subanalysis of WECAC (Women Coronary Artery Calcium) study HENDRAWAN T.(1), LUKITO A.A.(2) (1) Medical School Pelita Harapan Univercity, KARAWACI, INDONESIA ; (2) Siloam Hospital Lippo Village, KARAWACI, INDONESIA ID25 The comparison of lesion characteristics, angiographic and clinical outcome with Sirolimus-eluting stent, Paclitaxel-eluting stent, Zotarolimus-eluting stent and Everolimus-eluting stent 12 months after implantation TAKAMA T. Saiseikai Yokohama-City Eastern Hospitl, YOKOHAMA-CITY, JAPAN ID26 Three-year outcomes after the implantation of Sirolimus-eluting stent, Paclitaxel-eluting stent, and Zotarolimus-eluting stent for coronary artery disease in real world TAKAMA T. Saiseikai Yokohama-City Eastern Hospitl, YOKOHAMA-CITY, JAPAN ID27 Efficacy of using Dio instead of a guide catheter in transradial coronary intervention NAKACHI T., FUKUI K., NAKAGAWA T., OHKUSU Y., MUTO K., KATO S., KUSAKAWA Y., ISHII N. Kanagawa Cardiovascular and Respiratory Center, YOKOHAMA, JAPAN ID28 Impact of severity of diabetes on target lesion revascularisation in 5-year follow up after percutaneous coronary intervention with sirolimus eluting stents OKINO S., FUKUZAWA S., SUGIOKA J., IKEDA A., MAEKAWA J., ICHIKAWA S., KAMIOKA N., KUROIWA N., OKAMOTO S. Funabashi Municipal Medical Center, FUNABASHI, JAPAN ID29 ID32 The DIVERGE trial (drug-eluting stent intervention for treating side branches effectively): 3-year clinical results VERHEYE S.(1), DENS J.(2), DUBOIS C.(3), WORTHLEY S.(4), MCCLEAN D.(5), OTTERVANGER J.P.(6), MEREDITH I.(7), UREN N.(8), WIJNS W.(9), WHITBOURN R.(10), ORMISTON J.(11) (1) ZNA Middelheim Hospital, ANTWERP, BELGIUM ; (2) Zieknehuizen Oost Limburg St. Jan, GENK, BELGIUM ; (3) UZ Gasthuisberg, LEUVEN, BELGIUM ; (4) Royal Adelaide Hospital, ADELAIDE, AUSTRALIA ; (5) Christchurch Hospital, CHRISTCHURCH, NEW ZEALAND ; (6) Isala Klinieken, ZWOLLE, NETHERLANDS ; (7) Monash Medical Center, CLAYTON, AUSTRALIA ; (8) Royal Infirmary, EDINBURGH, UNITED KINGDOM ; (9) OLV Cardiovascular Center, AALST, BELGIUM ; (10) St. Vincent's Hospital, MELBOURNE, AUSTRALIA ; (11) Auckland City Hospital, AUCKLAND, NEW ZEALAND ID33 Fixed, low dose unfractionated Heparin for coronary angioplasty in acute coronary syndrome patients AGARWAL S.K., BASLAIB F.O., BINBREK A.S. Rashid Hospital, DUBAI, UNITED ARAB EMIRATES ID34 Left main coronary stenting in a non surgical octogenarian population: a possible approach DAHDOUH Z.(1), ROULE V.(2), LOGNONÉ T.(2), SABATIER R.(2), GROLLIER G.(2) (1) CHU de caen, CAEN, FRANCE ; (2) Cardiology, CAEN, FRANCE ID35 Prediction of future acute coronary syndrome in chest pain unit patients initially discharged with a negative evaluation CAMARO C., TEN CATE T., BROUWER M., CRAMER E., DE BOER M. UMC St Radboud, NIJMEGEN, NETHERLANDS ID36 Drug eluting balloon in daily clinical practice TEN CATE T., CAMARO C., HAUTH J., DE BOER M., SURYAPRANATA H. UMC St Radboud, NIJMEGEN, NETHERLANDS ID37 Safety and efficacy of early head-up strategy after femoral artery sheath removal. Single-center randomised controlled study KANESHIRO N., UTSUNOMIYA M., MASATO N., KAORU S. Toho University Ohashi Medical Center, TOKYO, JAPAN ID38 Direct aspiration of a large thrombus in acute myocardial infarction using a standard 6Fr guide catheter SHIMADA Y., KINO N., YANO K., TONOMURA D., TAKEHARA K., FURUBAYASHI K., KUROTOBI T., TSUCHIDA T., FUKUMOTO H. Shiroyama Hospital, HABIKINO, JAPAN ID39 Radiofrequency ablation in adults with tachycardia induced cardiomyopathy Index of microcirculatory resistance after elective percutaneous coronary intervention can predicts myocardial damage GEORGE G., SELVARAJ R., GOBU P., BABU E., SANTHOSH S., BALACHANDER J. JIPMER, PUDUCHERRY, INDIA SAIGUSA T. Shinshu University, MATSUMOTO, JAPAN ID40 ID30 Impact of acute coronary syndrome on clinical outcomes in patients with coronary bifurcation lesions treated with drug-eluting stents Predictor of microcirculatory damage after elective percutaneous coronary intervention SONG P.S., CHOI S.H., CHUNG S., SONG Y.B., HAHN J.Y., CHOI J.H., LEE S.H., GWON H.C. Samsung Medical Center, SEOUL, SOUTH KOREA SAIGUSA T. Shinshu University, MATSUMOTO, JAPAN ID41 ID31 Treatment of diabetic patients treated with a new generation drug-eluting stent: two-year clinical outcomes SANTOSO T.(1), DAMRAS T.(2), NAIR D.(3), WILKINS G.(4), SUNARYA S.(5), WALTERS D.(6), JAYASINGHE R.(7), WAN AHMAD W.A.(8), SIM K.H.(9), ONG T.K.(9), LOW A.(10), GHAPAR A.K.(11), KOH T.H.(12) (1) Medistra Hospital, JAKARTA, INDONESIA ; (2) Siriraj Hospital, BANGKOK, THAILAND ; (3) Tan Tock Seng Hospital, SINGAPORE, SINGAPORE ; (4) Dunedin Hospital, DUNEDIN, NEW ZEALAND ; (5) Harapan Kita Hospital, JAKARTA, INDONESIA ; (6) The Prince Charles Hospital, BRISBANE, AUSTRALIA ; (7) Gold Coast Hospital, QUEENSLAND, AUSTRALIA ; (8) University Malaya Medical Center, KUALA LUMPUR, MALAYSIA ; (9) Sarawak General Hospital, SARAWAK, MALAYSIA ; (10) National University Hospital, SINGAPORE, SINGAPORE ; (11) Serdang Hospital, SERDANG, MALAYSIA ; (12) National Heart Center Singapore, SINGAPORE, SINGAPORE ID42 Beacon II - a prospective, multi-centre, observational, real-world registry to assess clinical outcomes of patients after treatment with the BioMatrix stent SANTOSO T.(1), DENG X.W.(2), ZHANG X.M.(2), LIM V.(3), TRESUKOSOL D.(4), PHAM M.H.(5), QUANG HUAN D.(6) (1) Medistra Hospital, JAKARTA, INDONESIA ; (2) Kiang Wu Hospital, MACAO, MACAO ; (3) National Heart Center, SINGAPORE, MALAYSIA ; (4) Siriraj Hospital, BANGKOK, THAILAND ; (5) Vietnam Heart Institute, HANOI, VIETNAM ; (6) Heart institute of HCMC, HO CHI MINH, VIETNAM Effect of oral feeding of allium ascalunicom l. in thorasic aortia contractil response... FALLAHI F. Shahed university - cardiology department, TEHRAN, IRAN ID43 Percutaneous coronary intervention in patients with chronic total occlusion: CACTO (Complex Angioplasty & CTO Intervention Society - India) interventional data HORE D., VITHALA S., PLN K., SHAHA K. Global Hospitals, HYDERABAD, INDIA Final Programme / 12th-14th January, 2012 / Singapore 10 Interviews with last year's prize winners Interview with Yoshiaki Mitsutake Interview with Kin-Lam Tsui Clinical case winner 2011 and Assistant Professor of Cardiovascular Medicine in the Department of Internal Medicine at Kurume University School of Medicine, Japan How should I treat? case winner 2011, Director of the Cardiac Catheterisation Laboratory of Pamela Youde Nethersole Eastern Hospital, Hong Kong What was the subject of your case? My case title is “A juvenile with severe stenosis at the bilateral coronary artery ostium.” This was the case of a 15-year-old girl who presented with unstable angina. Her coronary angiogram revealed severe stenosis at the bilateral coronary artery ostium. We had the choice of implanting stents into her ostial lesions, but we considered the effects of long-term dual anti-platelet therapy to this young girl and finally selected CABG for her treatment. Afterwards, we performed VH-IVUS and OCT to evaluate the ostial lesions. Can you introduce yourself to the community? I am a Consultant Cardiologist and the Director of the Cardiac Catheterisation Laboratory of Pamela Youde Nethersole Eastern Hospital, Hong Kong. In AsiaPCR/SingLIVE 2011, I submitted the case titled "Left main stenosis and two CTOs in a patient with NSTEMI and cardiogenic shock" to the "How should I treat?" session. What was the subject of your case? The case highlighted the dilemma in choosing the optimal revascularisation strategy in this setting of acute coronary syndrome. The complex anatomy together with the unstable haemodynamic made PCI unfavourable and undoubtedly high-risk. On the other hand, PCI offered a prompt way for revascularisation and saving the patient. Why did you submit this case? Coronary ostial stenosis involving both coronary ostia is a rare occurrence. There have been few reports of bilateral coronary ostial stenosis in young subjects without known conventional coronary risk factors. In the absence of conventional coronary risk factors, coronary ostial narrowing has been reported in fibromuscular dysplasia, syphilitic aortitis, postradiation and Takayasu’s arteritis without any recognisable etiological background. Unfortunately, we could not identify the mechanism of our patient’s ostial lesions by blood, angiographic, intravascular imaging studies or pathological evaluation of the specimen obtained during surgery. However, we think one of the causes of sudden death in juveniles might be severe cardiac ischemia induced by coronary artery disease as in this case. What were the positive effects from winning the award? The "How should I treat?" session provided a good platform for fruitful discussion and an exchange of ideas among expert panellists from various regions. I was glad that the case attracted positive feedback and that I was awarded the Best "How Should I Treat?" Award. It encouraged me to further participate in interactive sessions of this kind. When the "How Should I Treat?" session was subsequently introduced in one of our regional meetings in collaboration with EuroPCR, I contributed to raise another complex case for discussion. What were the positive effects from winning the award? Winning this award has given me greater confidence in presenting data at international conferences. Do you recommend that your peers submit? I would certainly recommend to my peers to participate in this meaningful activity. Do you recommend that your peers submit? Yes, I do. What do you gain from AsiaPCR/SingLIVE? AsiaPCR/SingLIVE is definitely among the most educational and successful meetings held in Asia that allows participants to keep abreast of the developments in the field of interventional cardiology. What do you gain from AsiaPCR/SingLIVE? Through AsiaPCR/SingLIVE, I am able to build international collaborations. PCR courses are made by and for you! Your daily practice is that of many others - that’s why the Interactive Case Corner is pivotal to the entire community before, during, and after the Course. PCR Courses are made by and for the cardiovascular community starting with your case submissions, but your input reaches a community above and beyond the Course. Course Call for at PCRonline.com Before During After You submit your case You share your work with a small group You share it with the entire community PCRonline publishes PCR London Valves, AsiaPCR/SingLIVE, GulfPCR-GIM and EuroPCR cases. One year on the Interactive Case Corner section has seen: 2 89,997 pages viewed 2 13,019 visits 2 Average of 25 minutes spent per visit AsiaPCR/SingLIVE 2011 Complications hits: pages viewed 20,722 Next week, all the cases presented at AsiaPCR/SingLIVE will be online, join in the discussion! 11 Final Programme / 12th-14th January, 2012 / Singapore Interview Interview with Jack Tan Wei Chieh Guest Faculty, Cardiology Consultant with the Department of Cardiology and Director of the Coronary Care Unit at the National Heart Centre Singapore What is the disease pattern and burden of structural heart disease in Singapore? The demographics of the Singapore population is rapidly aging. By the year 2030, 19% of the population will be aged >65 years old in comparison to the current 7%. The most common and impactful structural disease will be degenerative aortic stenosis, affecting around 8% of individuals over 80 years of age. My guess is that around 3050% of such patients in Singapore with significant and symptomatic aortic stenosis do not receive surgical aortic valve replacement due to the high risk or to the patient’s reluctance for open surgical treatment. The most common structural heart disease is probably Mitral Valve Prolapse [MVP] with a reported prevalence to be around 5-15% in the general population. The mean and median age at presentation/detection in our local population is 42 and 38 years respectively. The population of patients who develop complications of MVP requiring surgical treatment is substantially lower at around 3% after initial detection during a mean follow up period of nine months. Treatment locally has been surgical mitral valve repair with a high success rate in patients with low surgical risk. Functional Mitral Regurgitation [MR] continues to increase in prevalence as survival for patients with impaired left ventricular systolic function improves. Isolated surgical repair for functional MR is rarely performed due to the patient co-morbidity and lack of demonstrable survival benefits. Rheumatic heart disease continues to contribute a small percentage of the structural heart disease in Singapore as the country has moved past third world status over the last few decades. Percutaneous transvenous mitral commissurotomy for mitral stenosis continues to be performed at our centre but at relatively infrequent intervals. There was an increasing trend of abortion for birth defects, accompanied by a falling trend in the congenital anomalies of live births due to early antenatal detection in Singapore. The most common of which continues to be cardiac at 9.07 per 1,000 live births. Atrial septal defects continue to be the most common congenital heart disease and since transcatheter device closure was introduced in Singapore in 1997, it has been the preferred choice over surgery for anatomically suitable patients. The favoured local device is the Amplatzer septal occluder. Tell us about the percutaneous valves intervention programmes (TAVI and MitraClip) in Singapore TAVI and the MitraClip procedures were adopted as the first in Asia at our centre in February 2009 and April 2011 respectively. Both programmes are multidisciplinary in nature and have surgeons, anaesthetists, interventional and echo cardiologists on the team. Both programmes currently select high-risk surgical patients deemed not suitable for open surgery by at least two surgeons and cases are discussed at our cardiac conferences. Our TAVI programme uses the CoreValve and the Edwards Sapian. Both transfemoral and transapical modes are employed. The initial 10 tens had two deaths from vascular and deployment complications using the older generation larger 22F Edwards sheath delivery system. The CoreValve system was adopted later. The later cases had a lower complication rate after the initial learning curve and better patient selection in our local population. Smaller built and vascular access challenges are true for our Asian population especially in elderly females. Eleven MitraClip cases have been successfully performed since April 2011 with no peri-procedural mortality. The majority of cases were performed for functional MR. Degenerative MR cases generally required a greater frequency of 2-clip deployment compared to functional MR. All patients had at least improved one functional New York Heart Association class status. Both programmes offer a gratifying treatment route for symptomatic non-surgical candidates. However, the high costs of treatment currently continue to limit widespread adoption. Do you think the number of TAVI cases will overtake surgical TAVI - And if so, why? I think the number of TAVI cases will overtake surgical TAVI because the sheath delivery sizes will continue to decrease with improved controlled deployment and repositionable devices on the horizon. What do you think of the future of devices in both AF and hypertension? Atrial fibrillation will inexorably continue to increase in prevalence as our population ages. The spectrum of devices available for atrial fibrillation includes pacing, ablation and atrial appendage occluders. New dedicated electrophysiology catheters and instruments for percutaneous or open surgical MAZE that increase successful rates in an idiotic proof and likely operative independent manner would be welcome. The tools available to a surgeon for curative AF treatment as a run-by shooting during concomitant coronary bypass and valve surgery are in need forbetter development for widespread adoption. Atrial appendage occluders, I think, will continue to be a niche area as the rapid adoption of effective and relatively safe use of oral, reversible direct thrombin inhibitors continue, unless the cost is contained within a routine AF ablation. New non-pharmacological therapies for hypertension continue to excite. Renal denervation through a minimally invasive approach using the Ardian Symplicity device appears to be safe in the short term with a low incidence of local complications and highly effective for resistant cases. If the effects were proven to be durable, the scopes of devices that would enter the market would be overwhelming due to the huge size of the market. The indications might also expand as more studies are on going for heart failure, cardio-renal syndrome, obstructive sleep apnoea, chronic renal failure, etc. Baroreflex activation devices that consist of a pulse generator and carotid-sinus leads that can lower blood pressure through stimulation of carotid baroreflex receptors, need to be proven as an effective therapy and might be more useful as a personalised anti-hypertensive adjunct for select patients. What do you think of AsiaPCR/SingLIVE and what is your vision for the future of the Course? The Course has been a happy marriage between our Centre and our European colleagues. Beyond overcoming cultural and time zone differences in working together, I believe we have benefited precisely because of these differences and exchange of expertise. The challenge for AsiaPCR/SingLIVE has always been to appeal to the varied audience that comes from surrounding regional countries with different cultures and practicing milieus. Now we also need to be cognisant of the increasing rate of attendees from varied European countries. I think the future of the Course lies in its relevance and ability to impart the simple and to adopt treatment guidelines in demonstrative cases that are inherently picked up across all cultural differences. Final Programme / 12th-14th January, 2012 / Singapore 12 Programme at a glance Thursday 12th Main Arena 09:00 10:00 11:00 09:30 10:30 11:30 Welcome Opening & live Live ceremony & How should demonstration Perspectives I treat? demonstration from from India on... Singapore 12:00 13:00 12:30 13:30 14:00 Room 2 Room 3 What's new in transradial interventions Room 201 Nurse/Technician Radiographer programme Abstracts PCI and ACS 16:00 15:30 Live Late demonstration breaking from trials Singapore Sponsored lunch symposium Abbott Vascular Topic: PCI in patients with complex left main disease Technical aspects of ASD/PFO closure 15:00 14:30 How should I treat? 16:30 17:00 17:30 Live The most demonstration educational from India cases 18:00 Wrap-up 08:30 Perspectives on... 08:00 Most educational case Wrap-up 07:30 18:30 19:00 19:30 20:00 Sponsored dinner symposium Biosensors International TOPIC: Complex PCI in patients with difficult subsets Renal denervation for resistant hypertension treatment Sponsored lunch symposium Minvasys Aortic balloon valvuloplasty: a bridge to TAVI LTT on transcatheter aortic valve implantation Nurses, technicians and radiographers forum - PART I Clinical case submissions forum I Sponsored dinner symposium Eurocor Abstracts Imaging PCI tips & tricks Update on vascular closure devices Nurses, technicians and radiographers forum - PART II Friday 13th Live demonstration from China Main Arena 10:00 11:00 10:30 11:30 12:00 The most Live demonstration educational cases from China How should I treat? 13:00 12:30 13:30 14:00 Sponsored lunch symposium Terumo TOPIC: PCI in patients with high-risk acute coronary syndrome Sponsored breakfast symposium Room 2 Sponsored lunch symposium Maquet Transcatheter mitral interventions Sponsored lunch symposium Hexacath Medtronic Sponsored breakfast symposium Meril Life Sciences Room 3 LTT on transseptal puncture techniques 16:00 15:30 16:30 Live demonstration from Singapore How should I treat? Left atrial appendage Percutaneous closure in paravalvular patients with leak closure atrial fibrillation Meet the experts Room 201 Stent complications High-risk acute coronary syndrome My most educational case 17:30 18:00 Live demonstration from Indonesia 18:30 19:00 Complications forum Update on invasive coronary imaging and functional lesion assessment (IVUS/OCT/FFR) PART 1 Meet the experts Meet the experts 17:00 TOPIC: PCI in patients with complex bifurcation lesion Abstracts Structural heart disease Clinical case submissions forum II 15:00 14:30 Live demonstration from Indonesia Wrap-up 09:30 The most educational cases 09:00 Perspectives on… 08:30 Wrap-up Chien Foundation Lectureship 08:00 Perspectives on… 07:30 How to write a paper PART 2 Clinical case submissions forum III Abstracts PCI and bifurcation stenting How to prepare and deliver an efficient PowerPoint presentation Room 208 Room 209 Imaging programme Guiding intervention with imaging: Viability imaging: which test? time for a re-think? Multimodality imaging for valvular interventions Imaging in the emergency department Saturday 14th 09:00 09:30 Live demonstration from Singapore 10:00 10:30 11:00 11:30 12:00 Live Live How How demonstration demonstration should I should I from from treat? treat? Singapore Singapore TOPIC: Non-coronary transcatheter interventions Main Arena Room 2 Room 209 Endovascular Endovascular case forum programme Sharing experience on coronary chronic total occlusion with experts New horizons in lower limb interventions Coronary / Structural heart / Hypertension 13:00 12:30 13:30 14:00 14:30 My most educational case: learn from the experts 15:00 15:30 16:00 16:30 17:00 Awards and closing ceremony 08:30 Keynote lecture 08:00 Perspectives on… 07:30 Interactive case-based review discussion Aortic aneurysm- evolving endovascular techniques Sponsored Daily Programme / 11th-12th October, / 12th-14th2010 January, / London 2012 / Singapore 13 Final How should I treat? Renal interventions: My worst nightmare: the end of renal artery complications session revascularisation? Nurse, Technician, Radiographer Imaging Endovascular Coronary / Structural / Hypertension scientific programme Thursday 12th 11:50-12:05 MAIN ARENA 08:40-12:10 MORNING TOPIC PCI in patients with complex left main disease in 2012 and beyond Objectives: ▸ To have a better understanding of the latest data ▸ To understand the specific indications for left main PCI in the Asia-Pacific region ▸ To learn the different left main stenting strategies 08:40-09:30 Live demonstration Welcome and live demonstration from the National Heart Centre Singapore Chairperson: T.H. Koh Co-chairperson: E. Eeckhout Panellists: J.J. Cheng, R. Gao, U. Kaul, J. Marco, M.C. Morice, P.W. Serruys ▸ Welcome - T.H. Koh 08:45-09:30 Live demonstration from the National Heart Centre Singapore 09:30-10:00 Opening ceremony Chairperson: T.H. Koh Co-chairperson: E. Eeckhout Panellists: J.J. Cheng, R. Gao, U. Kaul, J. Marco, M.C. Morice, P.W. Serruys ▸ Presentation of the Course and today's programme - T.H. Koh ▸ PCR family - J. Marco ▸ The three tools for coronary artery which I'm dreaming of - P.W. Serruys 10:00-10:20 Mini debate Perspectives on PCI in patients with complex left main disease Chairperson: T.H. Koh Co-chairperson: E. Eeckhout Panellists: J.J. Cheng, R. Gao, U. Kaul, J. Marco, M.C. Morice, P.W. Serruys ▸ Setting the stage - M.C. Morice ▸ My practice - R. Gao ▸ My practice - M.C. Morice ▸ My practice - U. Kaul ▸ What we have learned - T.H. Koh 10:20-11:05 How should I treat? session How should I treat? - PCI in patients with complex left main disease Chairperson: T.H. Koh Co-chairperson: E. Eeckhout Panellists: T.H. Ahn, A. Colombo, R. Gao, W.Y. Guo, A. Mehta, I. Meredith, Q.T. Nguyen, M.A. Rosli, T. Santoso, R. Zambahari ▸ Introduction - E. Eeckhout ▸ Case presentation - W.Y. Guo ▸ How would I treat? - M.A. Rosli ▸ How would I treat? - T.H. Ahn ▸ How did I treat? - W.Y. Guo ▸ Discussion ▸ Consensus - T.H. Koh 11:05-11:50 Live demonstration Live demonstration from Medanta Medicity, Gurgaon, India Chairperson: T.H. Koh Co-chairperson: E. Eeckhout Panellists: T.H. Ahn, A. Colombo, R. Gao, W.Y. Guo, A. Mehta, I. Meredith, Q.T. Nguyen, M.A. Rosli, T. Santoso, R. Zambahari “Call for” based session The most educational case on PCI in patients with complex left main disease Chairperson: T.H. Koh Co-chairperson: E. Eeckhout Panellists: T.H. Ahn, A. Colombo, R. Gao, W.Y. Guo, A. Mehta, I. Meredith, Q.T. Nguyen, M.A. Rosli, T. Santoso, R. Zambahari ▸ Severe left main distal stenosis treated by a new-dedicated bifurcation DES - J. Berland ▸ Discussion 12:05-12:10 Wrap-up Chairperson: T.H. Koh Co-chairperson: E. Eeckhout Panellists: T.H. Ahn, A. Colombo, R. Gao, W.Y. Guo, A. Mehta, I. Meredith, Q.T. Nguyen, M.A. Rosli, T. Santoso, R. Zambahari ▸ What we have learned today on PCI in patients with complex left main disease - W. Udayachalerm 12:15-13:30 Industry-supported session Are we ready to change? With an unrestricted educational grant from Abbott Vascular Chairpersons: T.H. Koh, J. Marco Panellists: M.W. Krucoff, S.T. Lim, P. Ong, P.W. Serruys, H.C. Tan ▸ Introduction and objectives - T.H. Koh ▸ Is newer always better? - M.W. Krucoff ▸ Can we reduce dual antiplatelet therapy (DAPT) to optimise PCI? - H.C. Tan ▸ Are we ready for vascular restoration therapy? - P.W. Serruys ▸ Discussion ▸ Take-home message - J. Marco 13:50-14:30 Late breaking trial session Late breaking trials Chairperson: J. Marco Co-chairperson: T.H. Koh Panellists: K.T. Chan, T. Cuisset, D.S. Gambhir, N.A.M. Momenuzzaman, M. Munawar, C.K. Naber, D. Tresukosol, W.A. Wan Azman ▸ Introduction - T.H. Koh ▸ The BASE-acute coronary syndrome trial: 18-month follow-up - P. Karjalainen ▸ Discussion ▸ INDICOR: the Paclitaxel-Eluting PTCA-balloon catheter in combination with a cobalt-chromium stent to treat coronary artery disease in a real world scenario - U. Kaul ▸ Discussion ▸ Summary - J. Marco 14:30-17:55 AFTERNOON TOPIC Complex PCI in patients with difficult subsets in 2012 and beyond Objective: ▸ To understand the best management revascularisation strategy for patients with: - depressed LV function - impaired renal function - calcified/diffused lesions 14:30-15:15 Live demonstration Live demonstration from the National Heart Centre Singapore Chairperson: J. Marco Co-chairperson: T.H. Koh Panellists: K.T. Chan, T. Cuisset, D.S. Gambhir, N.A.M. Momenuzzaman, M. Munawar, C.K. Naber, S. Sumitsuji, D. Tresukosol, W.A. Wan Azman Programme valid as of 28/12/2011. Subject to modification. Final Programme / 12th-14th January, 2012 / Singapore 14 Coronary / Structural / Hypertension scientific programme Thursday 12th - Main Arena 15:15-15:35 Mini debate Perspectives on complex PCI in patients with difficult subsets Chairperson: J. Marco Co-chairperson: T.H. Koh Panellists: K.T. Chan, T. Cuisset, D.S. Gambhir, N.A.M. Momenuzzaman, M. Munawar, C.K. Naber, S. Sumitsuji, D. Tresukosol, W.A. Wan Azman ▸ Setting the stage - C.K. Naber ▸ My practice - S. Sumitsuji ▸ My practice - C.K. Naber ▸ My practice - N.A.M. Momenuzzaman ▸ What we have learned - J. Marco 15:35-16:15 How should I treat? session How should I treat? - Complex PCI in patients with difficult subsets Chairperson: J. Marco Co-chairperson: T.H. Koh Panellists: K.T. Chan, T. Cuisset, D.S. Gambhir, N.A.M. Momenuzzaman, M. Munawar, C.K. Naber, S. Sumitsuji, D. Tresukosol, W.A. Wan Azman ▸ Case presentation - T. Cuisset ▸ How would I treat? - K.T. Chan ▸ How would I treat? - D.S. Gambhir ▸ How did I treat? - T. Cuisset ▸ Discussion ▸ Consensus - J. Marco Industry-supported session Does BA9 technology benefit your patients long-term? With an unrestricted educational grant from Biosensors International Chairpersons: T. Santoso, P.W. Serruys Panellists: K.T. Chan, F.H. Jafary, M. Munawar, A. Rosman, R. Tangco, C.J. Wu Objectives: ▸ To understand the impact of technology and its potential advantage on patient safety ▸ To educate on patient selection and the clinical relevance in daily practice ▸ To understand the unique application of a self-expanding dedicated bifurcation drug-eluting stent 18:00-18:30 Dinner ▸ Welcome and opening remarks - P.W. Serruys ▸ Lessons from BioMatrix and the BEACON II registry at three years - D. Tresukosol ▸ Very long-term outcomes with Biolimus A9 from an all-comers randomised clinical trial: LEADERS four-year data - P.W. Serruys ▸ Where dedicated bifurcation stents can benefit your patients: Axxess - the selfexpanding bifurcation Biolimus A9 eluting stent - S. Verheye ▸ Axxess case review: the first Asian experience - M.A. Rosli ▸ Axxess case review: the first Asian experience - C.Y.R. Fung ▸ Discussion ▸ Take-home message - T. Santoso ROOM 2 16:20-17:05 Live demonstration Live demonstration from Medanta Medicity, Gurgaon, India Chairperson: P.W. Serruys Co-chairperson: J.J. Cheng Panellists: P. Agarwal, J. Berland, S.L. Chen, H.C. Gwon, Y.L. Han, M.W. Krucoff, F. Mauri, M. Ochiai, W. Udayachalerm, C.J. Wu 17:05-17:50 18:00-20:00 “Call for” based session The most educational cases on complex PCI in patients with difficult subsets Chairperson: P.W. Serruys Co-chairperson: J.J. Cheng Panellists: P. Agarwal, J. Berland, S.L. Chen, H.C. Gwon, Y.L. Han, M.W. Krucoff, F. Mauri, M. Ochiai, W. Udayachalerm, C.J. Wu ▸ When surgery won't cut it...a complex problem with a percutaneous solution - P. Jain ▸ Discussion ▸ A small size isn't enough - M. Cardenas ▸ Discussion ▸ Intravascular ultrasound guided percutaneous coronary intervention with minimum contrast media - K. Kamishima ▸ Discussion 17:50-17:55 Wrap-up Chairperson: P.W. Serruys Co-chairperson: J.J. Cheng Panellists: P. Agarwal, J. Berland, S.L. Chen, H.C. Gwon, Y.L. Han, M.W. Krucoff, F. Mauri, M. Ochiai, W. Udayachalerm, C.J. Wu ▸ What we have learned today on complex PCI in patients with difficult subsets - T.H.S. Lo Programme valid as of 28/12/2011. Subject to modification. 15 Final Programme / 12th-14th January, 2012 / Singapore 10:15-11:05 Technical aspects of ASD/PFO closure Chairperson: J. Yip Co-chairperson: N.Q. Nguyen Panellists: A. Al Shafi Majumder, F. Kleber, H. Mehta, G. Sengottuvelu, R. Sethi, K.H. Srinivasa Objectives: ▸ To learn the different types of closure devices ▸ To learn about the different approaches of ASD closure ▸ To understand the current limitations and issues ▸ Introduction - J. Yip ▸ Overview of ASD/PFO closures - F. Kleber ▸ Complications from ASD implants - O. Muller ▸ Case presentation of complex ASD/PFO closures - L.H. Nguyen ▸ Case presentation of complex ASD/PFO closures - J.L. Tan ▸ Discussion 11:10-12:10 “Call for” based session PCI and acute coronary syndrome Chairperson: A. Wong Co-chairperson: H. Suryapranata Panellists: T. Ahmed, A. Erglis, I.C. Hsieh, S.W. Kyaw ▸ Introduction - A. Wong ▸ Efficacy of STEMI network in Southern Taiwan, a 3-year follow-up study - F.Y. Kuo ▸ Statin use decreased short-term and long-term major adverse cardiac events in acute myocardial infarction in patients with renal insufficiency - S.Y. Lim ▸ Comparison of clinical characteristics, 1-year readmission rates, cost and mortality amongst patients undergoing percutaneous coronary intervention for stable angina, acute coronary syndromes and ST-elevation myocardial infarction - K.K. Yeo ▸ Clinical characteristics and 1-year readmission rates, length of stay, cost and mortality in patients among men and women undergoing percutaneous coronary intervention - J.M. Fam ▸ Feasibility and safety of the 3Fr guiding sheath in percutaneous coronary interventions - D. Tonomura ▸ Take-home message - H. Suryapranata Coronary / Structural / Hypertension scientific programme Thursday 12th - Room 2 12:15-13:30 Industry-supported session Bifurcation dilemmas: case discussion on different treatment strategies With an unrestricted educational grant from Minvasys Chairperson: J. Fajadet Panellists: J. Berland, Y.S. Chong, D. Desai, B. Garcia Del Blanco, S.M. Hiremath Objectives: ▸ To understand the importance of being able to shift technical strategy during the procedure ▸ To assess the benefits of a provisional approach ▸ To understand the need for a dedicated stent design ▸ Introduction and objectives - J. Fajadet ▸ Bifurcations: be ready to modify your initial treatment strategy - S.M. Hiremath ▸ A complex bifurcation lesion case: options, discussion and solution B. Garcia Del Blanco ▸ A Medina 1,1,1 case: options, discussion and solution - D. Desai ▸ A left main case: options, discussion and solution - J. Berland ▸ Discussion ▸ Take-home message - J. Fajadet 14:00-14:50 Renal denervation for resistant hypertension treatment Chairperson: C.M. Chan Co-chairperson: S. Shetty Panellists: C.T. Chin, R. Khurana, S.S.L. Li, R. Zambahari Objectives: ▸ To understand the rationale for renal denervation in hypertension ▸ To have a critical overview of current data ▸ To learn on technical aspects ▸ Introduction - C.M. Chan ▸ Anatomy and physiology of the renal innervation - C.M. Chan ▸ Technical steps in renal denervation - S. Shetty ▸ Patient selection and data - R. Zambahari ▸ Case presentation of renal denervation - S.T. Lim ▸ Discussion 16:30-17:55 “Call for” based session Imaging Chairperson: T. Akasaka Co-chairperson: I. Meredith Panellists: J. Escaned, K.H. Lam, R. Thachathodiyl ▸ Introduction and objectives - T. Akasaka ▸ Optical coherence tomography assessment for Biolimus-eluting stents and Everolimus-eluting stents in the very early period - S. Kuramitsu ▸ Optical coherence tomography analysis for restenosis of Everolimus-eluting stents in comparison with bare metal stents and Paclitaxel-eluting stents - S. Enomoto ▸ Difference of neointimal appearance between early and late restenosis after Sirolimus-eluting stent implantation assessed by optical coherence tomography - H. Sougawa ▸ Relationship between systemic levels of inflammatory biomarkers and coronary artery thin-capped fibroatheroma - R. Tazaki ▸ Clinical impact of small-sized stent mal-apposition after stent implantation as detected by optical coherence tomography - A. Taruya ▸ Neointimal changes during an extended period after bare metal stent implantation: insights from integrated Backscatter Intravascular ultrasound - T. Haraguchi ▸ Dual axis rotational coronary angiography - the preferred mode of coronary angiography? - C.P. Lim ▸ Take-home message - I. Meredith 18:00-19:40 Industry-supported session Drug-eluting balloons - a viable alternative in PCI With an unrestricted educational grant from Eurocor Chairpersons: F. Malik, H.C. Tan Panellists: Y.S. Chong, R. Gotabhaya, A. Khan, S. Mohd Ali Objective: ▸ To understand and draw consensus on the use of drug-eluting balloons in expanding indications ▸ Introduction - F. Malik ▸ Technology behind a drug-eluting balloon - D. Dudek ▸ Drug-eluting balloon - the ideal indications - R. Khurana 18:25-19:10 Live demonstration from Apollo Hospitals, Hyderabad, India 14:55-16:25 “Call for” based session PCI tips and tricks Chairperson: S.T. Lim Co-chairperson: B. Chevalier Panellists: S. Dhakam, B. Hanif, O. Maskon, T.K. Ong, S. Rifqi Objectives: ▸ To learn tips and tricks from experts on how to avoid or resolve issues ▸ To learn how to improve manipulation of tools ▸ Introduction - S.T. Lim ▸ Coronary chronic total occlusion with two sesame doors - Y.S. Chong ▸ A novel way to manage oscillating/rocking/pulsating stent during PCI - S. Aziz ▸ A price to pay - M. Cardenas ▸ Intravascular ultrasound guided percutaneous coronary intervention with minimum contrast media - K. Kamishima ▸ Tips & tricks in CTO (antegrade approach) - A. Mehta ▸ Take-home message - B. Chevalier ▸ The clinical evidence - C.K. Naber ▸ Freeway - management of critical limb ischemia - B. Chua ▸ Discussion ▸ Take-home message - H.C. Tan ROOM 3 10:15-12:05 What's new in transradial interventions Chairperson: J. Fajadet Co-chairperson: C.J. Wu Panellists: F. Mauri, S. Mithrakumar, M. Munawar, O. Sakhov Objectives: ▸ To learn the current approach of TRI ▸ To appreciate the new developments in TRI ▸ Overview of current indications of TRI vs. TFI - O. Varenne ▸ Transulnar PCI - T.M. Patel ▸ Sheathless TRI - S. Sumitsuji ▸ Top 10 tips and tricks for TRI - C.J. Wu ▸ Complications of TRI - J. Fajadet ▸ Discussion ▸ Case presentation of TRI - W.A. Wan Azman ▸ Case presentation of TRI - B. Zhang ▸ Case presentation of TRI - A. Low ▸ Discussion Programme valid as of 28/12/2011. Subject to modification. Final Programme / 12th-14th January, 2012 / Singapore 16 Coronary / Structural / Hypertension scientific programme Thursday 12th - Room 3 14:00-14:55 Aortic balloon valvuloplasty: a bridge to TAVI Chairperson: G. Manoharan Panellists: C. Chan, M. Lee, M.A. Rosli, J.L. Soon, N. Wongpraparut Objectives: ▸ To understand when to perform BAV and lessons learned ▸ To learn technical aspects of the procedure ▸ Case selection and indications for balloon aortic valvuloplasty - R.I. Low ▸ How I do it - M. Thomas ▸ How I do it - P. Chiam ▸ Avoid and manage complications of balloon aortic valvuloplasty - E. Grube ▸ Discussion 15:10-16:40 LTT on transcatheter aortic valve implantation Facilitators: J. Fajadet, M. Thomas Panellists: E. Grube, M. Lee, G. Manoharan Objectives: ▸ To understand the current indications of TAVI and outcomes ▸ To learn technical aspects and issues of TAVI Live in-a-box® 16:55-17:55 MAIN ARENA 08:30-12:00 MORNING TOPIC PCI in patients with high-risk acute coronary syndrome in 2012 and beyond Objectives: ▸ To understand the current strategic approaches to high-risk acute coronary syndrome ▸ To understand how to integrate the new antiplatelet and antithrombotic agents in decision making in the Asia-Pacific region ▸ To understand the technical strategy for STEMI patients 08:30-09:20 Live demonstration Live demonstration from Shanghai Institute of Cardiovascular Diseases, Shanghai, China Chairperson: M.C. Morice Co-chairperson: T.H. Koh Panellists: T. Cuisset, S. Kar, T.H.S. Lo, R.I. Low, S. Nakamura, Q.T. Nguyen, A. Ong, A. Rahman, D. Walters ▸ Introduction - M.C. Morice Update on vascular closure devices Chairperson: K.K. Yeo Co-chairperson: G. Manoharan Panellists: S. Kum, M. Lim, S. Shetty, Y.K.K. Sin, S.G. Teo Objectives: ▸ To learn the various techniques of vascular access closure ▸ To learn how to avoid complications during vascular closure ▸ Collagen closure devices - K.K. Yeo ▸ Suture closure devices - J. Tan ▸ Complications of closure devices - M.C. Morice ▸ Device closure for large bore cannulations - G. Manoharan ▸ Discussion ROOM 201 10:15-12:15 Friday 13th “Call for” based session Clinical case submissions forum I Chairperson: K-H. Sim Co-chairperson: P. Karjalainen Panellists: R. Tangco, H. Trisnohadi ▸ A jailed coronary chronic total occlusion lesion - C.Y.R. Fung ▸ Double vessel stenting via 5 French diagnostic catheters using a new stent-on-awire - N. Shrestha ▸ VSD closure device - V. Kumar ▸ Right coronary artery CTO stenting in situs inversus dextrocardia - radial approach - S.S.R. Parupati ▸ A successful case of transradial PCI using microcatheter (ASAHI Corsair) and tapered-tip guidewire (Wizard 3) for tortuous right coronary artery coronary chronic total occlusion lesion - T. Yaguchi ▸ High risk left main bifurcation intervention - S. Wafa ▸ I wouldn't be alive (left main thromboaspiration) - K. Chhatrapati ▸ Triple vessel occlusion with no distal flow - O.K. George ▸ Through the rocks - A. Jain ▸ Lesion or no lesion - B. Pakshirajan Programme valid as of 28/12/2011. Subject to modification. 17 Final Programme / 12th-14th January, 2012 / Singapore 08:35-09:20 Live demonstration from Shanghai Institute of Cardiovascular Diseases, Shanghai, China 09:20-09:40 Mini debate Perspectives on PCI in patients with high-risk acute coronary syndrome Chairperson: M.C. Morice Co-chairperson: T.H. Koh Panellists: T. Cuisset, S. Kar, T.H.S. Lo, R.I. Low, S. Nakamura, Q.T. Nguyen, A. Ong, A. Rahman, D. Walters ▸ Setting the stage - T. Cuisset ▸ My practice - A. Ong ▸ My practice - T. Cuisset ▸ My practice - Q.T. Nguyen ▸ What we have learned - M.C. Morice 09:40-10:20 How should I treat? session How should I treat? - PCI in patients with high-risk acute coronary syndrome Chairperson: M.C. Morice Co-chairperson: T.H. Koh Panellists: T. Cuisset, S. Kar, T.H.S. Lo, R.I. Low, S. Nakamura, Q.T. Nguyen, A. Ong, A. Rahman, D. Walters ▸ Case presentation - D. Walters ▸ How would I treat? - A. Rahman ▸ How would I treat? - Q.T. Nguyen ▸ How did I treat? - D. Walters ▸ Discussion ▸ Consensus - T.H. Koh 10:25-11:10 Live demonstration Live demonstration from Shanghai Institute of Cardiovascular Diseases, Shanghai, China Chairperson: I. Meredith Co-chairperson: S.T. Lim Panellists: J.L Chen, J.C.Y. Chou, U. Kaul, F. Malik, T. Muramatsu, O. Varenne, S. Verheye Coronary / Structural / Hypertension scientific programme Friday 13th - Main Arena 11:10-11:55 “Call for” based session The most educational cases on PCI in patients with high-risk acute coronary syndrome Chairperson: I. Meredith Co-chairperson: S.T. Lim Panellists: J.L Chen, J.C.Y. Chou, U. Kaul, F. Malik, T. Muramatsu, O. Varenne, S. Verheye ▸ Resolution of intractable thrombus in DES - H. Hashidomi ▸ Discussion ▸ Do all LMCA occlusions require stenting/CABG? - R. Khaja ▸ Discussion ▸ An unusual case of acute coronary syndrome in a young lady - O. Muller ▸ Discussion 11:55-12:00 Wrap-up Chairperson: I. Meredith Co-chairperson: S.T. Lim Panellists: J.L Chen, J.C.Y. Chou, U. Kaul, F. Malik, T. Muramatsu, O. Varenne, S. Verheye ▸ What we have learned today on PCI in patients with high-risk acute coronary syndrome - M.A. Rosli 14:50-15:10 Mini debate Perspectives on PCI in patients with complex bifurcation lesion Chairperson: H.C. Tan Panellists: I.H. Chae, J.L Chen, W.Y. Guo, B. Chevalier, A. Colombo, F. Kleber, T.S. Kler, M. Nakamura, A. Pathan, A. Rahman ▸ Setting the stage - A. Colombo ▸ My practice - W.Y. Guo ▸ My practice - A. Colombo ▸ My practice - M. Nakamura ▸ What we have learned - H.C. Tan 15:10-15:50 How should I treat? session How should I treat? - PCI in patients with complex bifurcation lesion Chairperson: H.C. Tan Panellists: I.H. Chae, J.L Chen, W.Y. Guo, B. Chevalier, A. Colombo, F. Kleber, T.S. Kler, M. Nakamura, A. Pathan, A. Rahman ▸ Case presentation - J.L Chen ▸ How would I treat? - F. Kleber ▸ How would I treat? - A. Pathan ▸ How did I treat? - J.L Chen ▸ Discussion ▸ Consensus - H.C. Tan 12:00-12:10 15:55-16:40 Chien Foundation Lectureship Chairperson: I. Meredith Co-chairperson: S.T. Lim Panellists: J.L Chen, J.C.Y. Chou, U. Kaul, F. Malik, T. Muramatsu, S. Verheye, O. Varenne Live demonstration from the National Heart Centre Singapore Chairperson: R. Ng Co-chairperson: C.K. Naber Panellists: C. Chan, P. Chandra, Q.H. Do, S. Garg, E. Grube, A.A. Lukito, S.C. Ng, P.W. Serruys, A.F. Yahya 12:15-14:00 16:40-17:10 Industry-supported session Left main trunk and bifurcation - basics to practices With an unrestricted educational grant from Terumo Corporation Chairpersons: M.C. Morice, T.H. Koh Panellists: B. Chevalier, K.H. Lam, A. Low, F. Malik, T. Matsubara, G. Nakazawa, Y. Oikawa, T. Santoso, T. Yamashita, F. Yoshimachi Objectives: ▸ To understand left main trunk and bifurcation lesions histopathologically and the guidelines of procedure ▸ To learn tips and tricks through a live demonstration ▸ To reflect the knowledge gained of optimal procedure to daily practice ▸ Introduction and objectives - T.H. Koh ▸ Left main trunk and bifurcation: histopathological view - G. Nakazawa ▸ Current guidelines of left main trunk and bifurcation intervention - B. Chevalier Live demonstration “Call for” based session The most educational cases on PCI in patients with complex bifurcation lesion Chairperson: R. Ng Co-chairperson: C.K. Naber Panellists: C. Chan, P. Chandra, Q.H. Do, S. Garg, E. Grube, A.A. Lukito, S.C. Ng, P.W. Serruys, A.F. Yahya ▸ PCI of a critical bifurcating ostial stenosis of a dominant right coronary artery, involving the origin of large aberrant left circumflex - S. Aziz ▸ Discussion ▸ Rescue bifurcation angioplasty of a calcified left anterior descending/tortuous angulated diagonal lesion for cardiogenic shock in the setting of multiple comorbidities - S. Kubba ▸ Discussion 12:40-13:25 Live demonstration from the National Heart Centre Singapore 17:10-17:55 ▸ Drug-eluting stent for left main trunk and bifurcation (data from NOBORI 2) - T. Santoso ▸ Case review of left main trunk and bifurcation - Y. Oikawa ▸ Discussion ▸ Take-home message - M.C. Morice Live demonstration from Harapan Kita, Jakarta, Indonesia Chairperson: R. Ng Co-chairperson: C.K. Naber Panellists: C. Chan, P. Chandra, Q.H. Do, S. Garg, E. Grube, A.A. Lukito, S.C. Ng, P.W. Serruys, A.F. Yahya 14:05-18:00 AFTERNOON TOPIC PCI in patients with complex bifurcation lesion in 2012 and beyond Objectives: ▸ To understand how to implement the latest data in decision making for patients with complex bifurcation lesion ▸ To understand the latest techniques and technologies in the field ▸ To review the dedicated devices in the pipeline 14:05-14:50 Live demonstration 17:55-18:00 Wrap-up Chairperson: R. Ng Co-chairperson: C.K. Naber Panellists: C. Chan, P. Chandra, Q.H. Do, S. Garg, E. Grube, A.A. Lukito, S.C. Ng, P.W. Serruys, A.F. Yahya ▸ What we have learned today on PCI in patients with complex bifurcation lesion - G. Devlin Live demonstration Live demonstration from Harapan Kita, Jakarta, Indonesia Chairperson: H.C. Tan Panellists: I.H. Chae, J.L Chen, B. Chevalier, A. Colombo, W.Y. Guo, F. Kleber, T.S. Kler, M. Nakamura, A. Pathan, A. Rahman Programme valid as of 28/12/2011. Subject to modification. Final Programme / 12th-14th January, 2012 / Singapore 18 Coronary / Structural / Hypertension scientific programme Friday 13th ROOM 2 07:45-08:30 Industry-supported session Bringing cardiologists to the future With an unrestricted educational grant from Medtronic Chairpersons: S.T. Lim, R. Zambahari Panellists: Y.T. Lim, P. Ong, S. Shetty Objectives: ▸ To understand how to manage the challenges of the renal denervation procedure and how to simplify the treatment of complex coronary lesions ▸ To better understand the role of most advanced Medtronic technology to improve interventional cardiology treatments ▸ Introduction and objectives - S.T. Lim ▸ Renal denervation for resistant hypertension: challenges - S. Shetty ▸ Challenging PCI case at 5 o'clock on Friday: how Resolute Integrity helps to make the complex simple - P. Ong ▸ Discussion ▸ Take-home message - S.T. Lim 09:00-10:30 “Call for” based session Clinical case submissions forum II Chairperson: M. Thomas Panellists: Y. Koyama, S.C. Ng, A. Rosman, Y. Yuniadi ▸ Difficult retrograde crossing of the aortic valve - a valve in valve CoreValve case - M. Settergren ▸ Interventional exclusion of a false aneurysm of the ascending aorta with shunt into right atrium after supracoronary replacement for type A dissection - R. Birkemeyer ▸ Multivessel PCI via CoreValve TAVI graft - R. Linder ▸ Emergency percutaneous balloon aortic valvuloplasty using triple balloon technique as a bridge to surgical repair due to severe aortic stenosis with cardiogenic shock - K. Yamazaki ▸ Complex balloon mitral valvuloplasty - J.S.S. Murthy ▸ Dreaded complications during balloon mitral valvotomy - P. Gobu ▸ Device closure of ventricular septal defect complicated with myocardial infarction three weeks after coronary angioplasty - R. Barik 10:35-12:00 “Call for” based session Structural heart disease Chairperson: G. Devlin Co-chairperson: P. Chiam Panellists: R. Birkemeyer, Q.T. Nguyen, P. Radke, E. Tay ▸ Introduction and objectives - G. Devlin ▸ Mitral leaflet separation index as indicator of successful balloon mitral valvotomy - P. Gobu ▸ The contemporary outcome of fifty-two consecutive surgical transcatheter valve implantations performed in one year - J.L. Soon ▸ The association of body mass index with clinical outcome in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation - S. Stortecky ▸ Comparison of rotational angiography with multislice computed tomography for evaluation of the aortic root for transcatheter aortic valve replacement - C. Schultz ▸ Mitral leaflet separation index is an accurate measure for mitral stenosis - K. A. Alkhashab ▸ Transcatheter aortic valve implantation (TAVI) associated atrioventricular heart block in self-expandable CoreValve and balloon-expandable Edwards valves - M. Liang ▸ Is female gender itself a risk factor for development of severe pulmonary hypertension in secundum atrial septal defect? - S.C. Sinha ▸ Take-home message - P. Chiam Programme valid as of 28/12/2011. Subject to modification. 19 Final Programme / 12th-14th January, 2012 / Singapore 12:15-13:30 Industry-supported session How should I treat: the hemodynamically unstable STEMI patient With an unrestricted educational grant from Maquet Cardiovascular Chairperson: M. Thomas Panellists: G. Buchanan, A. Gnanaraj, K.W. Ho, S.T. Lim, Y.K.K Sin, R. Wessely Objectives: ▸ To learn what is the best treatment strategy for the heamodynamically unstable STEMI patient ▸ To understand the important role of mechanical support ▸ Introduction and objectives - M. Thomas Case 1 - Acute myocardial infarction + pre-shock ▸ Case presentation - K.W. Ho ▸ Discussion - R. Wessely ▸ What did I do? - K.W. Ho Case 2 - Acute myocardial infarction + Ventricular septal defect(s) ▸ Case presentation - G. Buchanan ▸ Discussion - Y.K.K. Sin ▸ What did I do? - G. Buchanan Case 3 - Acute myocardial infarction + shock ▸ Case presentation - A. Gnanaraj ▸ Discussion - S.T. Lim ▸ What did I do? - A. Gnanaraj ▸ Discussion 14:00-14:55 Left atrial appendage closure in patients with atrial fibrillation Chairperson: T.H. Koh Co-chairperson: S. Kar Panellists: K. Gunasegaran, Y.Y. Lam, M.C. Morice, W.S. Teo, D. Walters Objectives: ▸ To learn the current indications of LAA closure ▸ To learn about the current techniques and devices ▸ Introduction - T.H. Koh ▸ Overview of LAA closure devices and outcomes - S. Kar ▸ Watchman device implantation techniques - T.H. Koh ▸ AGA device implantation techniques - Y.Y. Lam ▸ Coherex - M.C. Morice ▸ Discussion ▸ Take-home message - S. Kar 15:00-15:55 Percutaneous paravalvular leak closure: a challenge for the Asia-Pacific interventionalist Chairperson: E. Eeckhout Co-chairperson: R.I. Low Panellists: S. Chandra, K.W. Ho, C.Y. Lee, L.H. Nguyen, Y.K.K. Sin Objectives: ▸ To understand the current indications ▸ To understand the specific imaging needs ▸ To learn the various approaches and techniques ▸ Indications, limitations and choice of device for percutaneous paravalvular leak closure - J. Tan ▸ Imaging assessment of percutaneous paravalvular leak - Z.P. Ding ▸ Case presentation: aortic paravalvular leak - R.I. Low ▸ Case presentation: mitral paravalvular leak - E. Eeckhout ▸ Discussion Coronary / Structural / Hypertension scientific programme Friday 13th - Room 2 16:00-18:00 “Call for” based session Complications submissions forum Chairperson: E. Eeckhout Co-chairperson: S.T. Lim Panellists: C.H.P. Ang, A. Erglis, L. Lam, T. Muthusamy , M. Yamin, B. Zhang ▸ The last option.... may something be saved? - M. Cardenas ▸ Blocked right coronary artery flow due to massive air embolisation during transseptal catheterisation - M. Fujino ▸ PTMC non deflating balloon - a rare complication - V. Bisane ▸ Contralateral reperfusion in right coronary artery to overcome bradyarrhythmia due to spiral dissection in left circumflex - B. Budiono ▸ How to fix a broken heart - E. Eeckhout ▸ PTCA complication - stent dislodgement in left anterior descending - R. Ghodeswar ▸ Aortic dissection following right coronary artery PCI - V. Gejapati ▸ My worst nightmare: multiple complications during very difficult left main-left anterior descending PCI - B. Faurie ROOM 3 07:45-08:30 Industry-supported session Learn from the experts With an unrestricted educational grant from Meril Life Sciences Chairperson: P.W. Serruys Panellists: T. Santoso, M. Munawar, M.A. Rosli Objective: ▸ To learn about the evolution of DES and techniques for left main, bifurcation and coronary chronic total occlusion ▸ Introduction and objectives - P.W. Serruys ▸ A decade of stent design: DES evolution - P.W. Serruys ▸ Techniques for left main - T. Santoso ▸ Treating bifurcation lesions - C.K. Naber ▸ Chronic total occlusions and perforations - A. Mehta ▸ Discussion 08:50-10:20 LTT on transseptal puncture techniques Facilitators: G. Ducrocq, J. Marco Panellists: N.Q. Nguyen, M.H. Pham, K.H. Srinivasa Objective: ▸ To learn the various technical aspects of transseptal puncture techniques Live in-a-box® 10:35-12:00 Transcatheter mitral interventions Chairperson: S. Kar Co-chairperson: K.K. Yeo Panellists: M.H. Pham, Y.K.K. Sin, R. Zambahari ▸ Introduction - S. Kar ▸ Choosing the right patient with mitral regurgitation for mitral clip interventions importance of echo evaluation - P. Ting ▸ How I do it - mitral clip step-by-step - K.K. Yeo ▸ Technical challenges and complications of mitral clip interventions - S. Kar ▸ Results and updates on mitral clip programme - R.I. Low ▸ Discussion ▸ Dreaded complications during balloon mitral valvotomy - P. Gobu ▸ Discussion ▸ Complex balloon mitral valvuloplasty - J.S.S. Murthy ▸ Discussion ▸ Take-home message - K.K. Yeo 12:15-13:30 Industry-supported session Titanium-nitride-oxide active stent: combining drug-eluting stent-like clinical efficacy with bare metal stent safety With an unrestricted educational grant from Hexacath Chairpersons: P. Karjalainen, P. Ong Panellists: M. Angioi, R. Khurana, M. Pietilä Objectives: ▸ To understand the full potential of Titanium-nitride-oxide coated stents ▸ To share the latest Titan2 clinical data (randomised clinical trial and registry) ▸ To better understand the Titanium-nitride-oxide interest in acute coronary syndrome patients ▸ Introduction and objectives - P. Ong ▸ Is platelet function testing important before elective PCI ? - R. Khurana ▸ Titan2 Bio Active Stent Singapore experience - P. Ong ▸ One-year clinical outcome of the large scale multicenter prospective registry in acute myocardial infarction with Titan 2 Bio Active Stent: the CATS-AMI registry - M. Angioi ▸ The BASE-acute coronary syndrome randomised study and BASE-OCT sub study at 18 months of follow-up - M. Pietilä ▸ Discussion ▸ Take-home message - P. Karjalainen 14:00-15:55 Imaging session Update on invasive coronary imaging and functional lesion assessment (IVUS/OCT/FFR) - Part I Chairperson: Y. S. Jang Co-chairperson: A. Low Panellists: K.T. Chan, Y. Koyama, T.K. Ong, D. Tresukosol Objectives: ▸ To appreciate the role of invasive imaging and physiology in PCI ▸ To learn image interpretation in complex scenarios ▸ To understand the current limitations of these technologies ▸ Opening remarks - A. Low ▸ The 10 most important new information/developments in IVUS imaging in 2012 - Y. S. Jang ▸ My most educational case on IVUS/OCT/FFR - K.T. Chan ▸ Case submission: Surprising IVUS - O. Gach ▸ My most educational case on IVUS/OCT/FFR - A. Low ▸ Case submission: Repeat myocardial infarction prospected by virtual histology - K. Hanada ▸ My most memorable complication with the use of IVUS/OCT/FFR - S. Sumitsuji ▸ IVUS/OCT/FFR quiz - Y. S. Jang 16:00-18:00 Imaging session Update on invasive coronary imaging and functional lesion assessment (IVUS/OCT/FFR) - Part II Chairperson: T. Akasaka Co-chairperson: S. Chia Panellists: Y.S. Chong, J. Escaned, N. Inoue, P. Karjalainen, S. Lee, P. Wong Objectives: ▸ To appreciate the role of invasive imaging and physiology in PCI ▸ To learn image interpretation in complex scenarios ▸ To understand the current limitations of these technologies ▸ The 10 most important new developments in coronary anatomy/physiology assessment (other than IVUS) - T. Akasaka ▸ How to assess arterial healing - S. Lee ▸ Case submission: Late stent thrombosis on top of fractured cypher stent presenting by STEMI - H. Shaalan ▸ My most educational case on IVUS/OCT/FFR - M. Nakamura ▸ Case submission: Culprit lesion in STEMI, missed by angiography and identified by OCT - W. Elabbassi ▸ IVUS/OCT/FFR quiz - T. Akasaka, S. Chia ▸ Round table discussion: angiography, IVUS, OCT, FFR...what are the major unmet imaging needs for practicing interventionist? ▸ Closing remarks - T. Akasaka Programme valid as of 28/12/2011. Subject to modification. Final Programme / 12th-14th January, 2012 / Singapore 20 Coronary / Structural / Hypertension scientific programme Friday 13th ROOM 201 09:00-09:55 Meet the experts - Stent complications Chairperson: P. Yan Co-chairperson: J. Escaned Panellist: T. Muthusamy Objectives: ▸ To provide practical answers to situations encountered during daily practice ▸ To improve stenting skill set 16:00-17:45 ▸ Overview of stent complications - A. Wong ▸ Stent loss - A. Erglis ▸ Stent thrombosis - P. Radke ▸ Late aneurysmal formation - J. Escaned ▸ Wrap-up - P. Yan “Call for” based session PCI and bifurcation stenting Chairperson: A. Seth Co-chairperson: G. Ducrocq Panellist: P. Tedjokusumo 10:00-10:55 Meet the experts - High-risk acute coronary syndrome Chairperson: M. Choo Co-chairperson: B. Sitanbaoli Panellists: R.C.H. Lee, V. Senaratne Objective: ▸ To learn practical issues in acute coronary syndrome scenarios ▸ Top 10 tips and tricks for primary PCI in STEMI - H. Suryapranata ▸ Acute coronary syndrome PCI in patients with active GI bleeding ▸ STEMI intervention with large thrombus burden - R. Khurana ▸ Acute coronary syndrome in poor LV function - T. Cuisset ▸ Wrap-up - M. Choo 11:00-11:55 Meet the experts - My most educational case Chairperson: Y.T. Lim Co-chairperson: D. Dudek Objective: ▸ To provide practical answers to situations encountered during daily practice ▸ Introduction and objectives - A. Seth ▸ The Tryton side branch stent system in left main disease - B. Scott ▸ The Tryton side branch stent system in left anterior descending - diagonal bifurcation in-stent restenosis - J. Sonck ▸ Predilatation of side branch during provisional T-stenting for true bifurcation - T. Kato ▸ Intravascular ultrasound results from the DIVERGE (drug-eluting stent intervention for treating side branches effectively) study - S. Verheye ▸ Influence of technique and anatomy on strut apposition in provisional stenting: insights from micro-computed tomography and optical coherence tomography - N. Foin ▸ Two-year clinical outcome with a new generation drug-eluting stent: a challenge in bifurcation treatment - B. Chevalier ▸ Repeated drug-eluting stent implantation for drug-eluting stent restenosis: first or second generation drug-eluting stent - K. Yamashita ▸ Overdilation of paclitaxel-eluting stent not associated with higher restenosis rates - K. Yamashita ▸ Two-year results: off label use of drug-eluting stent with biodegradable polymer - T. Santoso ▸ Take-home message - G. Ducrocq ROOM 208 ▸ Management of no reflow in PCI - O. Muller ▸ Left main PCI in cardiogenic shock - D. Dudek ▸ Trapped rotablator burr - S. Chia ▸ Case presentation ▸ Wrap-up - Y.T. Lim 15:30-17:00 How to prepare and deliver an efficient PowerPoint presentation A joint session EAPCI-PCR Educative Solutions Facilitator: J. Marco Discussants: T. Cuisset, G. Ducrocq, M.C. Morice, M. Thomas Objectives: ▸ To understand the strengths and weaknesses of PowerPoint as a support for a lecture or a teaching session ▸ To state the importance of a step-by-step process in 10 points to prepare a PowerPoint presentation ▸ To understand how to deliver a lecture based on a PowerPoint presentation 12:15-13:10 How to write a paper With the collaboration of EuroIntervention Chairpersons: E. Eeckhout, P.W. Serruys Panellist: J. Escaned Objective: ▸ To learn the tips and tricks for a successful publication ▸ Introduction - P.W. Serruys ▸ Common downfalls for medical papers - S. Garg ▸ Statistics tips and tricks - C. K. Naber ▸ How to review a medical paper - J. Escaned ▸ EuroIntervention Journal - P. Cummins ▸ PCR-EAPCI textbook - E. Eeckhout ▸ Take-home message - E. Eeckhout 13:55-15:55 ▸ Thrombus: a moving target - C. Yeo ▸ Newly developed giant right ventricular wall hematoma just after simple transradial coronary intervention - C. Kook-Jin ▸ Catheter tip embolisation into critical LMCA, emergency LMCA PCI - K. Vasudevan ▸ Stenting after retrograde recanalisation of Ao-right coronary artery bypass and left anterior descending chronic total occlusion - A. Osiev ▸ Large coronary aneurysm after coronary perforation in a rotational atherectomy procedure - E. Benit ▸ Primary PCI of an anomalous right coronary artery arising from the left coronary cusp using a left Judkins guiding catheter - V. Gejapati ▸ Complication of PCI (abscess) - A. Noeman ▸ Interactive session illustrated with concrete examples from PCRonline Saturday 14th MAIN ARENA “Call for” based session Clinical case submissions forum III Chairperson: P. Wong Co-chairperson: O. Muller Panellists: S.W. Kyaw, S. Rifqi ▸ Complication in management of acute MI in treated by emergency CABG and left ventricular assist device by extracorporeal membrane oxygenation - M. Bedossa ▸ PCI over a torturous, calcified and totally occluded right coronary artery - F.Y. Kuo Programme valid as of 28/12/2011. Subject to modification. 21 Final Programme / 12th-14th January, 2012 / Singapore 08:30-12:50 MORNING TOPIC Non-coronary transcatheter interventions in 2012 Objectives: ▸ To learn about patient selection, techniques and remaining issues for TAVI ▸ To learn about indications, techniques and remaining issues for ASD closure ▸ To understand the techniques and the potential of renal denervation for the treatment of resistant hypertension Coronary / Structural / Hypertension scientific programme Saturday 14th - Main Arena 08:30-09:20 Live demonstration 12:35-12:50 Live demonstration from the National Heart Centre Singapore Chairperson: S.T. Lim Co-chairperson: M. Thomas Panellists: W. Buddhari, Y.L. Chua, G. Devlin, J. Fajadet, A. Low, G. Manoharan, I. Meredith, C.K. Naber, M.A. Rosli, E. Tay My vision of the future of non-coronary transcatheter interventions Chairperson: A. Colombo Co-chairperson: P. Wong Panellists: S. Chandra, A. Chopra, S. Kar, T.H. Koh, O. Muller, L.H. Nguyen, A. Pathan ▸ Introduction - S.T. Lim ▸ My vision of the future of non-coronary transcatheter interventions - P.W. Serruys 08:35-09:20 Live demonstration from the National Heart Centre Singapore 09:20-09:40 Mini debate Perspectives on TAVI Chairperson: S.T. Lim Co-chairperson: M. Thomas Panellists: W. Buddhari, Y.L. Chua, G. Devlin, J. Fajadet, A. Low, G. Manoharan, I. Meredith, C.K. Naber, M.A. Rosli, E. Tay ▸ Setting the stage - M. Thomas ▸ My practice - M.A. Rosli ▸ My practice - M. Thomas ▸ My practice - I. Meredith ▸ What we have learned - S.T. Lim 09:40-10:20 How should I treat? session How should I treat? - TAVI Chairperson: S.T. Lim Co-chairperson: M. Thomas Panellists: W. Buddhari, Y.L. Chua, G. Devlin, J. Fajadet, A. Low, G. Manoharan, I. Meredith, C.K. Naber, M.A. Rosli, E. Tay ▸ Case presentation - C.K. Naber ▸ How would I treat? - W. Buddhari ▸ How would I treat? - G. Devlin ▸ How did I treat? - C.K. Naber ▸ Discussion ▸ Consensus - M. Thomas My most educational case: learn from the experts Chairperson: T.H. Koh Co-chairperson: E. Eeckhout Panellists: J. Fajadet, R. Gao, S.T. Lim, J. Marco, M.C. Morice, C.K. Naber, M.A. Rosli, P.W. Serruys, A. Wong ▸ A complete patient care - M.C. Morice ▸ Buried under the rock - A. Seth ▸ Case presentation - J. Fajadet ▸ Case presentation - S. Nakamura ▸ Management of a coronary perforation with tamponade - A. Colombo ▸ How to fix this leak - E. Eeckhout 14:25-14:55 Presentation of 2012 awards and closing ceremony Chairperson: T.H. Koh Co-chairperson: E. Eeckhout Panellists: J. Fajadet, R. Gao, S.T. Lim, J. Marco, M.C. Morice, C.K. Naber, M.A. Rosli, P.W. Serruys, A. Wong ▸ AsiaPCR/SingLIVE 2012 best abstracts - A. Wong ▸ AsiaPCR/SingLIVE 2012 best clinical case - S.T. Lim ▸ AsiaPCR/SingLIVE 2012 best How should I treat? - M.C. Morice ▸ AsiaPCR/SingLIVE in the future - J. Marco ▸ Highlights and closing remarks - T.H. Koh 10:20-11:05 Live demonstration Live demonstration from the National Heart Centre Singapore Chairperson: S.T. Lim Co-chairperson: M. Thomas Panellists: W. Buddhari, Y.L. Chua, G. Devlin, J. Fajadet, A. Low, G. Manoharan, I. Meredith, C.K. Naber, M.A. Rosli, E. Tay 11:10-11:50 12:55-14:25 How should I treat? session How should I treat? - LAA closure Chairperson: A. Colombo Co-chairperson: P. Wong Panellists: S. Chandra, A. Chopra, S. Kar, T.H. Koh, Y.Y. Lam, O. Muller, L.H. Nguyen, A. Pathan, R. Tangco ▸ Case presentation - T.H. Koh ▸ How would I treat? - R. Tangco ▸ How would I treat? - Y.Y. Lam ▸ How did I treat? - T.H. Koh ▸ Discussion ▸ Consensus - A. Colombo 11:50-12:35 ROOM 2 08:30-11:30 Sharing experience on coronary chronic total occlusion with experts Chairperson: A. Wong Co-chairperson: N. Inoue Panellists: J. Escaned, Y.L. Han, T.H.S. Lo, F. Mauri, T. Muramatsu, S. Nakamura Objectives: ▸ To learn and discuss pro and contra of the various techniques for complex coronary chronic total occlusion ▸ To explain the selection criteria and use of dedicated wires and other specific devices 08:30-09:20 Live demonstration from the National Heart Centre Singapore ▸ Current state of art in coronary chronic total occlusion approaches - T. Muramatsu 09:30-10:20 Live in-a-box® ▸ Update on reverse-cart techniques - N. Inoue 10:30-11:20 Live demonstration from the National Heart Centre Singapore Live demonstration Live demonstration from the National Heart Centre Singapore Chairperson: A. Colombo Co-chairperson: P. Wong Panellists: S. Chandra, A. Chopra, S. Kar, T.H. Koh, Y.Y. Lam, O. Muller, L.H. Nguyen, A. Pathan, R. Tangco ▸ Use of epicardial collateral channels - E. Tsuchikane 11:35-13:30 Interactive case-based review discussion Facilitator: J. Marco Panellists: F. Malik, A. Mehta, C.K. Naber, A. Rahman 11:50-12:20 Live demonstration from the National Heart Centre Singapore ▸ Indications - E. Eeckhout Programme valid as of 28/12/2011. Subject to modification. Final Programme / 12th-14th January, 2012 / Singapore 22 Special programme Nurses, technicians and radiographers forum The Nurses, technicians and radiographers Forum at AsiaPCR/SingLIVE this year is dedicated to the critical review of important practical issues in percutaneous coronary and structural interventions. The forum is specifically designed to meet the needs of experienced nurses, technicians and radiographers working in the field of interventional cardiology, taking into account local practices and constraints. The first part of this forum will include an interactive LTT session, with a special focus on “Scrubbing in for bifurcation PCI”. This session is developed to help our participants understand the indications for the procedure, all the elements of the decision-making process, technical aspects of device preparation as well as how to anticipate potential complications, using a recorded case to illustrate each step of the process. NEW IN 2012 The second half of the forum aimes to critically appraise current evidence for Cathlab management of STEMI and cardiogenic shock, as well as practical issues in using pressure wire in coronary intervention, chronic total occlusion interventions and obtaining optimal cineangiographic images. With the emergence of TAVI as an alternative to high-risk surgical aortic valve replacement, our speakers will also guide our audience through a systematic approach to TAVI and review the nursing management of potential acute complications. Through this interactive forum, the participants will be able to explore and understand current management of these important conditions and have the opportunity to challenge current practice in order to develop a clear consensus on how to deliver the best possible outcome in their own practice. Stanley Chia Veronica Kwok Programme Coordinators THURSDAY 12th ROOM 201 13:45-15:15 15:30-18:00 Nurses, technicians and radiographers forum - Part 1 Scrubbing in for bifurcation PCI Facilitators: S. Buendia, S. Chia, V. Kwok Panellists: G. Ducrocq, R.B.A. Ghani, W.Y. Guo Nurses, technicians and radiographers forum - Part 2 Chairperson: S. Chia Co-chairperson: V. Kwok Panellists: S. Buendia, R.B.A. Ghani Objectives: ▸ To learn the technical aspects of the device preparations ▸ To anticipate technical issues during PCI ▸ To learn how to manage complications Objectives: ▸ To learn the technical aspects of the device preparations ▸ To anticipate technical issues during PCI ▸ To learn how to manage complications Live in-a-box® ▸ Introduction and objectives - S. Chia ▸ Coordinated approach in the treatment of STEMI - J.J. Cheng ▸ Scrubbing-in for coronary chronic total occlusion intervention - R.B.A. Ghani ▸ Management of cardiogenic shock in the cathlab - S. Chia ▸ Practical issues in the setup and use of pressure wire in PCI - S. Buendia ▸ How to achieve optimal cineangiographic images in coronary interventions ▸ Step-by-step approach to TAVI - M. Thomas ▸ Nursing management of TAVI acute complications and co-morbid conditions - V. Kwok ▸ Question and answers ▸ Take-home message - V. Kwok Programme valid as of 28/12/2011. Subject to modification. 23 Final Programme / 12th-14th January, 2012 / Singapore Special programme Imaging sessions Cardiac imaging continues to evolve and has an increasingly crucial role in the performance of complex coronary and structural heart interventions. Our international speakers this year include Professor Sujith Seneviratne of Monash Heart Southern Health, who is both an interventional cardiologist and a leading expert on cardiac computed tomography. To highlight and improve our understanding of how to best make use of imaging in a wide range of settings, this year’s computed tomography and multimodality imaging programme will focus on several key themes. These include how the latest techniques in imaging can potentially help guide coronary interventions, the controversial issue of viability imaging prior to revascularisation, the pivotal contribution of imaging in valvular interventions, and the emerging role of imaging in the emergency room. Other experts will share their experience on the potential of cardiac MRI, how echocardiography is useful in percutaneous valve implantation and advances in cardiac computed tomography. If you have an interest in cardiac imaging, or wish to better understand how imaging can contribute to intervention, this programme is for you! Terrance Chua Course Co-Director FRIDAY 13th ROOM 209 08:45-11:00 13:35-15:30 Guiding intervention with imaging: which test? Chairpersons: F.K. Cheah, K-H. Sim Panellists: Y.J.F. Keng, S.Y. Tan Multimodality imaging for valvular interventions Chairpersons: P.P. Goh, M.A. Rosli Panellists: P. Chiam, S.H. Ewe Objectives: ▸ To learn the strengths and limitations of each imaging method ▸ To understand how to better choose the right test for each clinical situation Objectives: ▸ To learn how to use imaging for valvular intervention ▸ To understand the strengths and limitations of each technique ▸ Opening remarks - S.J.T. Chua ▸ Keynote lecture: the role of cardiac computed tomography in interventional cardiology - S. Seneviratne ▸ Case-based discussion: cardiac magnetic resonance imaging - the one test that does it all? - A.S. Low ▸ Case-based discussion: is there still a role for nuclear cardiology in 2012? Y.J.F. Keng ▸ Case-based discussion: stress perfusion imaging using cardiac computed tomography - K.T. Ho ▸ Questions and answers ▸ The role of computed tomography in valvular interventions - S.Y. Tan ▸ The role of echo in valvular interventions - Z.P. Ding ▸ Case-based discussion: aortic valve disease - P. Chiam ▸ Case-based discussion: mitral valve disease - K.K. Yeo ▸ Questions and answers 11:00-12:15 Objective: ▸ To understand the potential role and limitations of imaging in the emergency department using computed tomography and/or nuclear imaging Viability imaging: time for a re-think? Chairpersons: S.J.T. Chua, H.Y. Ong Objectives: ▸ To have a better understanding of the latest trial data on viability testing ▸ To learn how it can help us to select patients for revascularisation ▸ Approach to the patient with impaired left ventricular function - K.K. Poh ▸ Case-based discussion: viability imaging after STICH - R.S. Tan ▸ Case-based discussion: a surgeon's perspective on viability - Y.L. Chua ▸ Questions and answers 15:30-17:00 Imaging in the emergency department Chairpersons: S.Y. Tan, Q.W. Yong Panellists: YS.J.T. Chua, .J.F. Keng ▸ Keynote lecture: computed tomography for acute chest pain - ready for prime time? - S. Seneviratne ▸ Case-based discussion: chest pain in the emergency room - the nuclear option S.J.T. Chua ▸ Questions and answers ▸ Closing remarks - S.J.T. Chua Programme valid as of 28/12/2011. Subject to modification. Final Programme / 12th-14th January, 2012 / Singapore 24 Special programme Endovascular sessions Endovascular interventions continue to grow in range and complexity. The programme for 2012 will be held on 14th January 2012 to enable interested participants to be more focused. The faculty featured will be experts from around the world and from South East Asia. Among the featured topics are lower limb interventions, the treatment of aortic aneurysms and new techniques like renal denervation. These will be workshop style sessions to enable maximum interaction between faculty and participants. The talks will be complemented by case-based learning, which are presented and discussed by a panel of experts. The ever popular ‘Complications’ session will be a highlight of the programme, where experts share their nightmare cases in a learning environment. The programme will be of interest to all specialists practicing in the vascular arena, including vascular specialists, radiologists, surgeons and cardiologists, and doctors-in-training in these fields. Bien-Soo Tan Course Co-Director SATURDAY 14th 07:30-08:20 ROOM 209 "Call for" based session Endovascular Case Forum Chairperson: B.S. Tan Co-chairperson: S.T. Lim Panellists: A. Gogna, F. Irani ▸ Introduction - S.T. Lim ▸ Endovascular salvage intervention for 10 year aortoiliac occlusion - H.L. Huang ▸ Angiojet thrombectomy in the acute subclavian artery thrombosis patient - T.Y. Wu ▸ Post renal transplant - graft renal artery stenting in a complex anatomy S.S.R. Parupati ▸ Successful endovascular treatment of spontaneous abdominal aortic dissection in Takayasu's arteritis - K. Narayanan ▸ Immediate normalisation of blood pressure following intervention in functional total occlusion of unilateral renal artery with an atrophic kidney - P. Singh ▸ Take-home message - B.S. Tan 08:30-10:30 New horizons in lower limb interventions Chairperson: K.H. Tay Panellists: M. Chen, E. Liu Objectives: ▸ To update the guidelines for critical limb ischaemia management ▸ To demonstrate a step-by-step approach for superficial femoral artery and below the knee interventions ▸ To share the latest techniques for superficial femoral artery and below the knee interventions ▸ Critical limb ischemia - update on management guidelines - S.P. Chng ▸ Superficial femoral artery interventions - an update - M. Spanger ▸ Superficial femoral artery intervention SAFARI technique - recorded case T.N. Yeow ▸ Is there a role for drug-eluting stent and drug-eluting balloon in the lower limb interventions? - D. Rajan ▸ Below the knee intervention - recorded case - M. Burgmans 10:30-12:30 Aortic aneurysms - evolving endovascular techniques Chairperson: Y.K.K. Sin Panellists: P. Robless, D. Wong Objectives: ▸ To demonstrate the latest techniques in endovascular and hybrid management of thoracic and abdominal aortic aneurysms ▸ To demonstrate a step-by-step endovascular approach to aortic aneurysms ▸ Branched endografts for thoracic and abdominal aneurysms - D. Rajan ▸ Abdominal aortic aneurysm - recorded case - F. Irani ▸ The chimney technique - M. Taneja ▸ TA - recorded case - V. Chao ▸ Hybrid procedures - K.H. Tay 12:30-14:00 How should I treat? session How should I treat? Chairperson: M. Taneja Panellists: Y.T.P. Goh, Z. Kyaw Objective: ▸ To learn advanced endovascular techniques from various experts through interactive case based discussions ▸ Case presentation - M. Spanger ▸ How would I treat? - D. Rajan ▸ How did I treat? - M. Spanger ▸ Case presentation - M. Chen ▸ How would I treat? - D. Wong ▸ How did I treat? - M. Chen ▸ Case presentation - K.S. Ng ▸ How would I treat? - D-D. Do ▸ How did I treat? - K.S. Ng 14:10-15:30 Renal interventions: the end of renal artery revascularisation? Chairperson: T.N. Lau Panellists: G.C. Chua, D. Rajan, J. Tan Objectives: ▸ To discuss the current status of renal artery revascularisation ▸ To discuss new techniques in hypertension management ▸ To demonstrate the technique of percutaneous denervation ▸ Renal artery angioplasty and stenting - is it obsolete? - S. Punamiya ▸ New techniques for hypertension management - S. Shetty ▸ Renal denervation - recorded case - S. Shetty 15:30-17:00 Clinical case session My worst nightmare: complications session Chairperson: B.S. Tan Panellists: S. Kum, P. Sidipratomo Objective: ▸ To learn how to avoid and manage complications through a panel of experts sharing their cases and lessons learned ▸ Case presentation - M. Azeemuddin ▸ Case presentation - U. Pua ▸ Case presentation - K.K. Yeo ▸ Case presentation - A. Tang ▸ Case presentation - D-D. Do ▸ Discussion ▸ Take-home message - B.S. Tan Programme valid as of 28/12/2011. Subject to modification. 25 Final Programme / 12th-14th January, 2012 / Singapore Training programme Thursday 12th 07:30 08:00 08:30 09:00 09:30 10:00 ABBOTT VASCULAR Room 203 10:30 11:00 11:30 12:00 13:30 14:00 14:30 15:00 15:30 16:00 16:30 17:00 Virtual simulator, Endovascular Optical coherence tomography Fractional flow reserve CORDIS Room 205 Vascular closure device Vascular closure device BOSTON SCIENTIFIC Room 206 Vascular closure device LAA closure technology Rotablator atherectomy system MAQUET CARDIOVASCULAR Room 207 Intra-aortic balloon pump & intra-aortic balloon catheter 07:30 08:30 09:30 10:30 11:30 Cardiogenic shock high-risk PCI 12:30 ABBOTT VASCULAR Room 203 13:30 14:30 Intra-aortic balloon pump & intra-aortic balloon catheter 15:30 16:30 MitraClip therapy, Endovascular ST JUDE MEDICAL Room 204 Fractional flow reserve Optical coherence tomography CORDIS Room 205 Vascular closure device Vascular closure device BOSTON SCIENTIFIC Room 206 Vascular closure device LAA closure technology Rotablator atherectomy system MAQUET CARDIOVASCULAR Room 207 Intra-aortic balloon pump & intra-aortic balloon catheter Saturday 14th 07:30 08:00 08:30 09:00 09:30 ABBOTT VASCULAR Room 203 10:00 10:30 Intra-aortic balloon pump & intra-aortic balloon catheter 11:00 11:30 12:00 Cardiogenic shock high-risk PCI 12:30 Intra-aortic balloon pump & intra-aortic balloon catheter 13:00 Coronary chronic total occlusion guide wires tip sharing, Virtual simulator CORDIS Room 205 Vascular closure device MAQUET CARDIOVASCULAR Room 207 Intra-aortic balloon pump & intra-aortic balloon catheter Thursday 12th Room 203 13:00 Side branch access stent, MitraClip therapy, Coronary chronic total occlusion guide wires tip sharing, ST JUDE MEDICAL Room 204 Friday 13th 12:30 Vascular closure device Cardiogenic shock high-risk PCI 09:30-12:00 14:00-17:00 ABBOTT VASCULAR 09:30-12:00 14:00-17:00 Training village MitraClip therapy Trainer: P. Wray Objective: ▸ To increase current understanding of the MitraClip therapy and procedure 09:30-12:00 14:00-17:00 Training village Coronary chronic total occlusion guide wires tip sharing Trainer: I. Haruna Objective: ▸ To learn basic technique and tips and tricks of guide wires shaping for coronary chronic total occlusions Training village Virtual simulator Trainer: S. Yen Objective: ▸ To learn basic PCI and EVT procedure and techniques 09:30-12:00 14:00-17:00 Training village Endovascular Trainer: R. Kwan Objectives: ▸ To learn the basic technique on large hole wound closure ▸ To understand the building blocks of peripheral guide wires and balloons 10:30-12:00 15:00-16:30 Training village Side branch access stent Trainer: F. Guenther Objective: ▸ To understand the fundamental characteristic of side branch access stent technology Programme valid as of 28/12/2011. Subject to modification. Final Programme / 12th-14th January, 2012 / Singapore 26 Training programme Programme valid as of 28/12/2011. Subject to modification. Thursday 12th Room 204 ST JUDE MEDICAL 09:00-17:00 Training village Hands-on workshop Objectives: ▸ To emphasize on the PCI optimisation with optical coherence tomography and fractional flow reserve technology ▸ To provide an advanced hands-on training designed to demonstrate AngioSeal deployment 11:00-12:00 Training village Optical coherence tomography Trainer: S. Chia Objectives: ▸ To learn how to prepare the optical coherence tomography console and catheter for image acquisition. ▸ To learn basic optical coherence tomography image intepretation ▸ To recognise common image artifacts ▸ To understand the limitations of optical coherence tomography 16:00-17:00 Training village Fractional flow reserve Trainer: R. Khurana Objectives: ▸ Fractional flow reserve versus IVUS ▸ To learn how to prepare the fractional flow reserve console and pressure wire Room 205 CORDIS CORPORATION A Johnson & Johnson company 09:30-10:30 11:30-12:30 14:00-15:00 Training village 09:00-17:00 BOSTON SCIENTIFIC Training village WATCHMAN LAA closure technology Trainer: J. Mahdi Training village WATCHMAN LAA closure technology Trainer: S. Kar Objectives: ▸ To introduce the concept/clinical need for LAA closure ▸ To provide an overview of the Watchman LAA Closure procedure ▸ To review and discuss key clinical data on the Watchman device 09:00-17:00 11:30-12:30 15:00-16:00 Training village CARDIOSAVE - Intra-Aortic Balloon Pump; SENSATION PLUS - Intra-Aortic Balloon Catheter Trainers: A. Neitzert, C. Surmann Objectives: ▸ To provide an insight into the newest technology and the benefits for both user and patient ▸ To understand the positive effects of the bigger sized balloon ▸ To have a better understanding of the significance of speed in challenging patients 13:30-14:30 Training village Therapy update: cardiogenic shock; high risk PCI Trainers: A. Neitzert, C. Surmann Objectives: ▸ To know how to handle cardiogenic shock during primary PCI ▸ To understand the role of hemodynamic support during high-risk PCI ▸ To reemphasise that the benefits of counterpulsation therapy outweigh the risks Friday 13th Room 203 09:30-12:00 14:00-17:00 ABBOTT VASCULAR Training village MitraClip therapy Trainer: P. Wray 09:30-12:00 14:00-17:00 Training village Rotablator atherectomy system Trainer: P. Becker Objectives: ▸ To demonstrate the use of the Rotablator system for treatment of calcified lesions, with a complete family of products ▸ To provide an overview of the importance of pre-treatment of calcified lesion with rotational atherectomy 27 Final Programme / 12th-14th January, 2012 / Singapore Training village Endovascular Trainer: R. Kwan Objectives: ▸ To learn the basic technique on large hole wound closure ▸ To understand the building blocks of peripheral guide wires and balloons Room 204 09:00-17:00 Objectives: ▸ To introduce the concept/clinical need for LAA closure ▸ To provide an overview of the Watchman LAA Closure procedure ▸ To review and discuss key clinical data on the Watchman device 12:00-14:00 MAQUET CARDIOVASCULAR Objective: ▸ To increase current understanding of the MitraClip therapy and procedure Cordis Exoseal vascular closure device hands-on workshop Trainers: A. Tan, B.Y. Yeoh Objectives: ▸ To get a thorough overview of the new Cordis Exoseal vascular closure device, a safe and effective tool ▸ To have hands-on experience with this new device Room 206 Room 207 ST JUDE MEDICAL Training village Hands-on workshop Objectives: ▸ To emphasize on the PCI optimisation with optical coherence tomography and fractional flow reserve technology ▸ To provide an advanced hands-on training designed to demonstrate AngioSeal deployment 09:30-10:30 Training village Fractional flow reserve Trainer: J. Tan Objectives: ▸ To understand physiological versus morphology approach ▸ To undesrtand the importance of Hyperemia ▸ To learn the practical pitfalls in the use of fractional flow reserve 11:00-12:00 Training village Optical coherence tomography Trainer: Dr Zhang Objective: ▸ To use optical coherence tomography to give the physician insight for enhanced revascularisation decision making Training programme Friday 13th Room 205 CORDIS CORPORATION A Johnson & Johnson company 09:30-10:30 11:30-12:30 14:00-15:00 Training village Room 203 ABBOTT VASCULAR 09:30-12:00 Cordis Exoseal vascular closure device hands-on workshop Trainers: A. Tan, B.Y. Yeoh Objectives: ▸ To get a thorough overview of the new Cordis Exoseal vascular closure device, a safe and effective tool ▸ To have hands-on experience with this new device Room 206 BOSTON SCIENTIFIC 09:00-17:00 Training village WATCHMAN LAA closure technology Trainer: J. Mahdi Objectives: ▸ To introduce the concept/clinical need for LAA closure ▸ To provide an overview of the Watchman LAA Closure procedure ▸ To review and discuss key clinical data on the Watchman device 09:00-17:00 Training village Rotablator atherectomy system Trainer: P. Becker Objectives: ▸ To demonstrate the use of the Rotablator system for treatment of calcified lesions, with a complete family of products ▸ To provide an overview of the importance of pre-treatment of calcified lesion with rotational atherectomy 12:00-14:00 Training village WATCHMAN LAA closure technology Trainer: S. Kar Objectives: ▸ To introduce the concept/clinical need for LAA closure ▸ To provide an overview of the Watchman LAA Closure procedure ▸ To review and discuss key clinical data on the Watchman device Room 207 Saturday 14th MAQUET CARDIOVASCULAR 10:00-11:00 11:30-12:30 15:00-16:00 Training village CARDIOSAVE - Intra-Aortic Balloon Pump; SENSATION PLUS - Intra-Aortic Balloon Catheter Trainers: A. Neitzert, C. Surmann Objectives: ▸ To provide an insight into the newest technology and the benefits for both user and patient ▸ To understand the positive effects of the bigger sized balloon ▸ To have a better understanding of the significance of speed in challenging patients 13:30-14:30 Training village Coronary chronic total occlusion guide wires tip sharing Trainer: I. Haruna Objective: ▸ To learn basic technique and tips and tricks of guide wires shaping for coronary chronic total occlusions 09:30-12:00 Training village Virtual simulator Trainer: S. Yen Objective: ▸ To learn basic PCI and EVT procedure and techniques Room 205 09:30-10:30 11:30-12:30 CORDIS CORPORATION A Johnson & Johnson company Training village Cordis Exoseal vascular closure device hands-on workshop Trainers: A. Tan, B.Y. Yeoh Objectives: ▸ To get a thorough overview of the new Cordis Exoseal vascular closure device, a safe and effective tool ▸ To have hands-on experience with this new device Room 207 10:00-11:00 MAQUET CARDIOVASCULAR Training village CARDIOSAVE - Intra-Aortic Balloon Pump; SENSATION PLUS - Intra-Aortic Balloon Catheter Trainers: A. Neitzert, C. Surmann Objectives: ▸ To provide an insight into the newest technology and the benefits for both user and patient ▸ To understand the positive effects of the bigger sized balloon ▸ To have a better understanding of the significance of speed in challenging patients 11:30-12:30 Training village Therapy update: cardiogenic shock; high risk PCI Trainers: A. Neitzert, C. Surmann Objectives: ▸ To know how to handle cardiogenic shock during primary PCI ▸ To understand the role of hemodynamic support during high-risk PCI ▸ To reemphasise that the benefits of counterpulsation therapy outweigh the risks Training village Therapy update: cardiogenic shock; high risk PCI Trainers: A. Neitzert, C. Surmann Objectives: ▸ To know how to handle cardiogenic shock during primary PCI ▸ To understand the role of hemodynamic support during high-risk PCI ▸ To reemphasise that the benefits of counterpulsation therapy outweigh the risks Programme valid as of 28/12/2011. Subject to modification. Final Programme / 12th-14th January, 2012 / Singapore 28 News from the Chien Foundation Third annual AsiaPCR/SingLIVE Chien Foundation Lectureship awarded to Dr. Richard Ng The presentation of this prestigious award will take place this Friday January 13th in the Main Arena at noon. The Chien Foundation Lectureship award was introduced in 2008 and seeks to honour and show appreciation to outstanding teachers and promoters in education and research in interventional cardiology in AsiaPacific countries. This year’s awardee Dr Richard Ng studied at our University of Singapore Medical College and also briefly at the University of Dundee DRI (Dundee Royal Infirmary) as an exchange scholarship student. He graduated in 1970 and three years later, in 1973, was awarded the Master of Medicine (Internal Medicine) in Singapore, MRACP in Australia and MRCP in London. He proceeded on a Fellowship to London National Heart Hospital in 1975 and was a staff Registrar for three years. He worked with many well-known cardiologists and cardiac surgeons but one of his distinctions was to be Anthony Rickards’ first Registrar. In 1997, he furthered his cardiology fellowship at Cedars-Sinai Medical Centre with Dr Jeremy Swan. He returned to Singapore in 1978 as a Senior Lecturer in Medicine at the University of Singapore. By 1980, Dr Ng left at the early age of 35 years to work in newly established private practice, Mount Elizabeth Medical Centre; continuing also as a Visiting Consultant to the Ministry of Health. By his own initiative and expense, Dr Ng went to study with Richard Myler and Simon Stertzer at the San Francisco Heart Institute for a short fellowship in 1984, learning the very beginnings of percutaneous transluminal coronary angioplasty [PTCA]. Following this fellowship, he brought home equipment to carry out the first three successful balloon PTCA at Mount Elizabeth Hospital. This was presented in the Academy of Medicine, Singapore and, in 1986, he presented his 19 cases of balloon PTCA to the Academy of Medicine Annals. Dr Ng truly is the father of PTCA in Singapore, and probably Asia, as all these cases were carried out without any foreign expertise in his catheter lab at Mount Elizabeth. In 1978, he organised the first live PTCA course in Singapore at Mount Elizabeth Hospital with guest experts from the USA and Europe and concluding successfully with 15 patients. He has been a very active member of the cardiology community, not just in Singapore, but also on the international circuit. His humble and dedicated nature has earned him an extensive global network of friends and associates, besides a faithful client base. Dr Ng is one of the early pioneers of Singapore’s participation and involvement in many professional and international conferences and cardiac societies. Through his vision to bring unity and recognition to the different cardiac societies in the region, he also organised many local, regional and international cardiology associations and meetings. Designed to reduce the learning curve of the heart team 2012 EDITION 30th September - 2nd October He has been elected President of the Singapore Cardiac Society for nine separate terms. Dr Ng has also been a very active President and Advisor in the Asian Federation of Cardiology and has done charity work in cardiology in China, Myanmar, Vietnam, Indonesia, Laos and East Malaysia. He is the Founding Director of the ASEAN College of Cardiology and the founding president of the Asian Pacific Society of Interventional Cardiology that was established in 1990. He is an active board member for many charitable foundations and organisations. Last but not least, Dr Ng has played a key and vital role in the formation and vitality of Chien Foundation. His ideas and contributions have benefitted many interventionists in the Asia-Pacific region in the area of education, training and research. His modest and gentle manners belie a dynamic character who places importance on helping others, especially the younger and weaker members of the community, to assist them to achieve their best. A man who places great value on integrity and generosity, in his own quiet and unassuming way, he has been an ambassador in the world of interventional cardiology, bringing and bridging people and ideas together for the good and advancement of healthcare for Singapore, the Asia-Pacific region and beyond. Join the Chien Foundation Lectureship Friday 13th - Main Arena 12:00 - 12:10 29 Final Programme / 12th-14th January, 2012 / Singapore www.pcrlondonvalves.com EuroIntervention Journal EuroIntervention at AsiaPCR/SingLIVE 2012 Patrick W. Serruys, Editor-in-Chief, EuroIntervention We can say that the world we live in is growing smaller each day, and that may be true in our ability to communicate, to travel, to exchange ideas and experience. But it is our differences, our unique and individual ways of looking and experiencing that world, that offer us the most tangible opportunities to improve ourselves and our practice. My years of experience dealing with my Asian colleagues have taught me that, and I owe them easily as much as I have offered to them. For these reasons I see meetings such as AsiaPCR/ SingLIVE as essential to the evolution of our work, and I look forward, as I have for over thirty years, to this valuable exchange. Although this is the third time I will be present at AsiaPCR/SingLIVE 2012, it will be the first time that EuroIntervention will have a prominent role. I will be chairing, with Eric Eeckhout, in my capacity as Editor-in-Chief of the journal the "Tips & tricks for a successful publication" session. This session has become, since its inception at EuroPCR, a resounding success. At this year’s session in Paris, we noticed that a significant group of attendees came from the Middle East and the Pacific Rim, with our friends and colleagues from far afield participating in lively discussions with the experts. An invitation was quickly forthcoming from the AsiaPCR/ SingLIVE 2012 Directors to launch the session in Singapore,which we gladly accepted. The session will include helpful suggestions in the art of writing, avoiding the common pitfalls, how to review a medical paper and also provide tips with statistics. The session will provide a unique platform for discussions, for you to seek answers or advice of the invited experts to become a successful writer or reviewer. Our last issue of Eurointervention, December 2011, illustrates this growing success with some interesting papers published from the Pacific Rim. EuroIntervention is but one arm of PCR Publishing and during the session, we will present also a sneak preview of PCR-EAPCI textbook which will be launched at EuroPCR 2012. Together with the Editors of the book, let me assure that this book, although a mammoth undertaking with over 90 chapters encompassing the whole scope of our interventional field, is a fantastic educative endeavour of which we all are very proud of. As many iPad users will know (I too am one of the 25 million - June 2011), that EuroIntervention is freely available as an app at the iTunes store and 2012 will also see PCR Publishing present the OCT interactive atlas, exclusively published on the iPad. Finally, on behalf of the Editors of EuroIntervention and our presenters, I cordially invite you to the “Tips & tricks for a successful publication” session on 13/01/201 in room 201 at 12:15-13:10. We look forward not only in the coming months, but also in the long term, to submissions to EuroIntervention. How to write a paper Friday 13th - Room 201 12:15-13:10 SEE YOU NEXT YEAR www.asiapcr.com Final Programme / 12th-14th January, 2012 / Singapore 30 Interview Interview with Jun-Jack Cheng Programme Committee Member, Director of the Medical Department of Shin Kong Hospital, Secretary General of Taiwan Society of Cardiology and Course Director of Taiwan Transcatheter Therapy (TTT) Please tell us about yourself? I am Doctor Jun-Jack Cheng, the Director of the Medical Department of Shin Kong Hospital in Taipei, the Secretary General of the Taiwan Society of Cardiology, and also the Course Director of Taiwan Transcatheter Therapy (TTT 2011-2014). When you are committed to something, especially in the medical field, there is a lot to contribute. Time and money are always a problem, but by making an effort, I have been able to gratify my desire to contribute. Cooperating with different societies, it is my goal not only to bolster the newest intervention techniques, but also to learn fresh ideas from different doctors on how to approach my goals. How has the current evidence influenced your approach in patients requiring left main intervention and in Taiwan as a whole? Is there any consensus? Asian people traditionally don’t prefer operation because they believe that the incidence of mortality is high, therefore the majority (>90%) of patients with coronary artery disease in Taiwan choose intervention. The current evidence and guidelines will not influence our approach and we always do our best to achieve the best results through the most delicate techniques. From Asian data (Korea, Taiwan etc.), PCI is safe for most patients with left main lesions, except those with a high Syntax score. If you have a patient with left main bifurcation lesion, do you prefer PCI or CABG? For patients with left main bifurcation, I would prefer PCI, keeping CABG (less than 10%) for those with complex lesions (3VD with diffuse, coronary Chronic Total Occlusion [CTO]). In left main PCI, do you prefer transradial or transfemoral? Since 1998, the transradial approach of PCI has been transformed from an alternative to the femoral into a routine method in our centre, with enough experience and intimate knowledge of guide behaviour, complex interventions like primary angioplasty (80%), left main bifurcation (>90%) and CTO PCI (50%) can be safety and easily performed via the radial route. This method achieves an excellent procedural success rate, virtually eliminates access site complications (bleeding) and allows rapid ambulation. What do you think of AsiaPCR/SingLIVE and what is your vision for the future of the Course? AsiaPCR/SingLIVE is one of the pioneers of the PCI live demonstration in Asia and even in the world. In the past, there were only a few countries like Japan. Malaysia, Korea and Taiwan joining in AsiaPCR/SingLIVE, but now with other countries like India, Arabia and the Middle East participating, the Course is even more fruitful. I hope we can continue to receive different representatives of different societies and discuss, debate the different topics together. Competition between different groups always attracts an audience. rendez-vous in PARIS 15TH-18TH MAY 2012 www.europcr.com Final Programme / 12th-14th January, 2012 / Singapore 32 Interviews Interview with Ashwin Mehta Guest Faculty and Interventional cardiologist at Jaslok Hospital & Research Centre in Mumbai, India Tell us about yourself and your involvement in the cardiology community in India. In 1987, we preformed our first angioplasty at Jaslok Hospital & Research Centre in Mumbai, India and now our cumulative figure could be close to 10,000 angioplasties. I had the opportunity to introduce high-risk angioplasty with percutaneous cardiopulmonary support, laser myocardial revascularisation, and the intra-aortic balloon pump, one of the first in the country. Currently, we are actively studying fractional flow reserve in bifurcating lesions and IVUS in coronary chronic total occlusion. I was both President of the Cardiological Society of India in 2000 and of the World Congress of Coronary Disease in 1981 and 1986. Currently, I am actively involved in teaching programmes on both the basics and complex interventional cardiology. I have been a regular faculty member at EuroPCR and, a couple of years ago, I was assigned a Learning The Techniques session on CTO at EuroPCR in Paris. Do you see any increase in the number of PCI in India after the Syntax trial or the reverse? After the Syntax trial the number of angioplasties at my centre has gone up and this is perhaps true for the entire country. Moderate and low-risk Syntax cases are more confidently handled with intervention. As the second most populated nation in the world, how accessible and affordable is PCI to the general population in India? There is approximately 20% growth in the number of angioplasty procedures every year in India, but we still have a long way to go. India should be doing approximately a million procedures per year. The limitations are the cost constraints and affordability of the procedure. The majority of people bear the cost of their medical expenses by themselves, but both government support and insurance-based support are slowly increasing, making angioplasty available to patients more easily than ever before. Any suggestions that would improve the above? People in India have many false impressions about angioplasty. They believe that surgery is a permanent cure and that angioplasty is a short lasting palliative procedure. Once they understand the role of intervention and the positive and negative aspects in comparison to surgery, they will be in a better position to accept or reject angioplasty when offered. What do you think of AsiaPCR/SingLIVE and what is your vision for the future of the Course? AsiaPCR/SingLIVE is an excellent venue for the promotion and growth of knowledge in the field of intervention. It is still in its infancy, but it is becoming more and more popular. The excellent scientific content, beautiful hotels, excellent facilities and the closeness to India are some of the major factors, making AsiaPCR/SingLIVE an important Course contributing to knowledge in interventional cardiology. Interview with Fazila Malik Guest Faculty, Professor and Chief Consultant Cardiologist at the National Heart Foundation Hospital & Research Institute in Dhaka, Bangladesh What is your role or participation in the cardiology community in Bangladesh? As the chief consultant of a tertiary cardiac centre, I am trying to lead the effort to perform and maintain the high quality of coronary interventions. My aim is to introduce the latest technology in coronary intervention in Bangladesh and to train young cardiologists in intervention and clinical cardiology. I also participate in different international multicentre registries and organise an annual international cardiac conference, the National Heart Foundation Conference on Cardiovascular Disease. What is the penetration rate of DES in your country and what factors affect its usage? In 2010 there were approximately 2,200 stents implanted in my centre, of which 90% were DES. When implanting a DES we take the clinical presentation, vessel condition and the economic status of the patient into account. If I have a STEMI, I would prefer bare metal stent or DES, because... As a general offer in our centre we use BMS in primary PCI, but at the same time, I advocate the use of DES to those who can afford it as recent trials using DES in primary PCI have shown encouraging results. What do you think of AsiaPCR/SingLIVE and what is your vision for the future of the course? Asia PCR/SingLIVE is a grand gathering of cardiologists from Asia and all over the world. It is the perfect platform for exchanging views and ideas and bringing ourselves up to date not only with the latest information, but also with the achievements of our colleagues. I believe, as an organisation of the most populous continent, AsiaPCR/SingLIVE will help to spread the benefits of coronary interventions among the nations. The experience continues @ pcronline.com Final Programme / 12th-14th January, 2012 / Singapore 34 Singapore Night Life Singapore: never a dull moment! t There is something for everyone in Singapore! This truly cosmopolitan city is in constant movement even long after the sun goes down, providing you with plenty of options for putting your feet up and relaxing after a full day of learning and sharing. Whether you want to enjoy a meal, toast with your peers, or network after hours, Singapore has something to offer. The Marina Bay district t In Singapore, the sky is the limit. Take in the jaw-dropping panorama from the most advantageous viewpoints: overlook the Marina Bay from the rooftop of the Esplanade while enjoying drinks and dinner at the Orgo restaurant. Appreciate the entire island city at dusk during the 32-minute rotation on the Singapore Flyer or visit Singapore’s newest entertainment destination, the Marina Bay Sands Hotel! Not only is this the largest hotel in Singapore with three 55-storey towers complete with luxury shopping, dining, and world-class entertainment facilities, but this building is also an architectural feat. Topping off the three towers is the Sands SkyPark with an observation deck, gardens, restaurants and a swimming pool all over 200 metres in the sky leaving a lasting impression! t Little India, Chinatown and Kampong Glam - get your culture & heritage fix Discover Singapore’s distinct neighbourhoods offering an abundance of excellent restaurants, chic bars and amusing after-hours activities. Do you smell spices or incense? You are most certainly in Little India! Explore this vibrant district and experience the authenticity of its restaurants and shops. Head over to Chinatown and rub shoulders with the locals at the Maxwell Road Food Centre. With over 100 stalls, you’re sure to sample some of the best hawker food in town! Or get caught up in the bustling and colourful Kampong Glam district. Stray from the beaten path of Orchard Road and meander down of Haji Lane to get the best boutique shopping experience Singapore has to offer! t In the heart of the city - close to nature Want to get some fresh air away from the bustling city? You don’t have to go far. Head over to the Botanic Gardens located in the centre of town and wander through the virgin rain forest until midnight. Take in the National Orchid Garden's collection of 1,000 orchid species and 2,000 hybrids. Prefer beaches to forests? Get a change of scenery strolling along 7.5 km of sandy beach at East Coast Park and take a load off at one of the many cafés or bars. This beachside distraction won’t disappoint! 35 Final Programme / 12th-14th January, 2012 / Singapore Find your hotel! Wilk ie Rd No rth Br idg eR d Vi cto ria Qu ee n St St d ch R Bea 2 MANDARIN ORIENTAL***** 5 Raffles Avenue, Marina Square, 039797 Singapore 4 ’s R d Republic Blvd Hw y Suntec Tower 4 as ah Rd Suntec Tower 3 2 Ra ffle sb lvd 3 5 Millenia Tower Marina Promenade Marina Square Marina Leisureplex Raffles Ave 3 PAN PACIFIC***** 7 Raffles Boulevard, Marina Square, 039595 Singapore East Coast Pkwy Marina Bayfront City Esplanade Mall 1 CARLTON HOTEL**** 76 Bras Basah Road, 189558 Singapore Rd Suntec City Nic oll Hw y Bra sB Esplan ade D r Funan Centre Raffles City St An dre w Rd No rth Bri dg e Hill St Riv er Va lle yR d Rd Raffles Shopping Arcade Ni co ll Be ac hR d Vi ct or ia Sta mf ord The Substation Ro ch or Shaw Towers St National Museum of Singapore 1 Ophir Rd Singapore Br Art Museum as Ba sa h Rd 5 THE RITZ-CARLTON MILLENIA SINGAPORE***** 7 Raffles Avenue, 039799 Singapore 4 CONRAD CENTENNIAL SINGAPORE***** Two Temasek Boulevard, 038982 Singapore The success of the 2012 edition of AsiaPCR/SingLIVE would not be possible without you! ! t r o p p u s r u o y r o f Thank you Abbott Vascular EMS ACIST MEDICAL SYST - TCTAP Angioplasty Summit . Angiovention Co., Ltd D LT . CO ASAHI INTECC Ltd B. Braun Singapore Pte l Technologies Pte Ltd na Biosensors Interventio Biotronik SE & Co. KG BOSTON SCIENTIFIC CID SpA company , a Johnson & Johnson CORDIS CORPORATION ORATION ELIXIR MEDICAL CORP Eurocor CERC lar Research Centre European Cardiovascu HEXACATH ces Info Ressources Servi D LT E PT INNOHEART y Co., Ltd. Japan Stent Technolog ATION OR KANEKA MEDIX CORP logy (Beijing) Co., Ltd Lepu Medical Techno lar MAQUET Cardiovascu IONAL, Ltd AT RN MEDTRONIC INTE Ltd. t. Meril Life Sciences Pv MINVASYS NTRE SINGAPORE NATIONAL HEART CE Pte Ltd OrbusNeich Medical P.G. BOOKS PTE LTD Pie Medical Imaging bH Medizinprodukte Gm Qualimed Innovative ResearchBooks Asia SANOFI SIEMENS HEALTHCARE ST JUDE MEDICAL Ltd TemMed Medical Co., N SINGAPORE BRANCH IO TERUMO CORPORAT translumina GmbH TRANSMEDIC PTE LTD ation ZOLL Medical Corpor 2/2011 tic order, valid as of 23/1 Classification in alphabe Final Programme / 12th-14th January, 2012 / Singapore 36 The A-Z of AsiaPCR/SingLIVE 2012 Access Food & beverage Opening hours MRT: Esplanade Station or City Hall Interchange. Bus: Lines 36, 97, 106, 111, 133, 501, 502, 518, 857, 700. Breakfast Bento boxes will be served during Industry breakfast symposia Friday 13th outside rooms 2 and 3 at 7:45. Tea and coffee served all day in the exhibition area. Coffee break Served in the exhibition area: Thursday 12th: 8:35 and 16:15 Friday 13th: 10:00 and 16:00 Saturday 14th: 10:00 Lunch Buffet lunch open around 12:00 in the exhibition area. Bento boxes and meal boxes served outside the session rooms at 12:15. Dinner Served during Industry dinner symposia on Thursday 12th in front of the Main Arena and room 2 at 18:00. Onsite registration Wednesday 11th: Thursday 12th: Friday 13th: Saturday 14th: Scientific sessions Thursday 12th: Friday 13th: Saturday 14th: Exhibition area Thursday 12th: Friday 13th: Saturday 14th: Badge Registration badges must be worn at all times. Access to the exhibition area and rooms will not be permitted without a valid and visible badge. Bag pick-up Located on Level 1, registration area, Suntec Main Entrance. Case corner Review the complications and clinical cases selected from the “call for” on dedicated computers. Located in the exhibition area with the cyber kiosk. See also Interactive case corner for interactive discussions schedule. Free Preview room: Wednesday 11th: Thursday 12th: Friday 13th: Saturday 14th: 16:00 - 19:00 7:00 - 20:00 7:00 - 18:00 7:00 - 17:00 8:40 - 20:00 7:45 - 18:00 7:30 - 17:00 7:30 - 20:00 7:00 - 18:00 8:00 - 15:00 16:00 - 19:00 7:00 - 20:00 7:00 - 18:00 7:00 - 17:00 Your badge includes access to all scientific sessions and the exhibition area. PLUS lunches and coffee breaks Photography See "Food". Hotels Posters gallery Certificate of attendance A Carlson Wagonlit representative will be available at the registration desk to help with your queries. See page 36 to find the list. Information also available on the smartphone applications. Download it now at www.asiapcr.com! Catering A certificate of attendance will be delivered with your badge at the registration desk. Cloakroom Located near the registration desk. Leave your luggage free of charge. Open during registration hours. Convention Centre Suntec Singapore International Convention & Exhibition Centre 1 Raffles Boulevard, Suntec City, Singapore 039593 Cyber kiosk Located in the exhibition area. Free access to computers connected to Internet. Delegate lounge A place to network with colleagues or relax located in the exhibition area. EuroIntervention Journal The official journal of the European Association of Percutaneous Cardiovascular Interventions. Pick-up your free copy at the distribution point. Exhibitors See the exhibition map. Information also available with the smartphone application. Interactive case corner A unique concept from PCR! Come along and share with your peers at the Interactive Case Corner, where the atmosphere is friendly, free of judgment, pressure and timelines. Case discussion is a great learning experience, combined with well-rounded educational messages, this will complete your educational experience at AsiaPCR/Sing LIVE 2012. The Interactive Case Corner is tucked away in a quiet corner of the exhibition hall. Internet Free WiFi is available in selected areas, follow the WiFi signs. If you need a computer, feel free to use the Cyber kiosk, located in the exhibition area. Language English is the official language of AsiaPCR/SingLIVE. Lost and Found Lost property can be found at the Exhibitor Support Centre. Located on Level 2. Photography and filming are strictly prohibited. Visit the poster area and participate in the moderated discussions: Thursday 12th 16:30 - 17:30 with Eric Eeckhout and Aaron Wong Friday 13th 9:00 - 10:00 with Wan Ahmad Wan Azman and Philip Wong Friday 13th 15:00 - 16:00 with Fina Mauri and Andrew Ong Preview room Located in room 210, for speakers & presenters only. Please upload your slides 3 hours before your presentation. Open starting Wednesday 11th at 16:00. Registration Pre-registration: if you have pre-registered, go to the "Pre-registered" counter. On-site registration: go to the “On-site” counter. Session room capacity Each session room has a limited capacity and we are unable to reserve seats, therefore once the room is full, for security reasons we will be unable to permit further access. Smartphones An application dedicated to the Course is available for Android, iPhone. Includes: breaking news, scientific programme with a “What’s on now” option, exhibitors and more. Download it now at www.asiapcr.com! Smoking Exhibitor Support Centre The entire Convention Centre is a non-smoking area. For exhibitors only. Information office located on Level 2 near the exhibition area. Tourism You will find guides to Singapore in your delegates bag. Visits of Singapore Visitors desk on level 1 of the Suntec City Mall, near the entrance of the Convention Centre and the Food Republic restaurant. 37 Final Programme / 12th-14th January, 2012 / Singapore Plans Interactive Case Corner Room 3 Room 2 Room 206 Room 205 Room 207 Room 204 Training Village Exhibition Hall Exhibition Hall Room 208 Room 203 Room 209 Preview Room Main Arena Room 201 Posters Gallery Main Entrance Entrance ZONE 1 ZONE 2 DAY PASS AND FULL PASS ACCESS ONLY ALL TYPES OF BADGES ZONE 1 ZONE 2 Interactive Case Corner Exhibition Area Buffet 1 20 9 21 1 18 7 12 14 15 16 22 23 24 25 26 27 28 29 30 31 32 38 37 Buffet Room 2 33 34 35 36 Room 3 1 2 6 Buffet 9 4 5 7 8 10 Lounge 40 Main Arena Main Entrance ZONE 1 Cyber Cafe 1 2 4 5 6 7 8 9 10 12 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 40 BOSTON SCIENTIFIC MAQUET Cardiovascular ELIXIR MEDICAL CORPORATION Meril Life Sciences Pvt. Ltd. TERUMO CORPORATION SINGAPORE BRANCH Abbott Vascular HEXACATH Biosensors Interventional Technologies Pte Ltd Biotronik SE & Co. KG Qualimed Innovative Medizinprodukte GmbH translumina GmbH TemMed Medical Co., Ltd ZOLL Medical Corporation P.G. BOOKS PTE LTD Info Ressources Services ResearchBooks Asia Angioplasty Summit - TCTAP Angiovention Co., Ltd. KANEKA MEDIX CORPORATION TRANSMEDIC PTE LTD ST JUDE MEDICAL European Cardiovascular Research Centre - CERC ACIST MEDICAL SYSTEMS SIEMENS HEALTHCARE Japan Stent Technology Co., Ltd ASAHI INTECC CO. LTD B. Braun Singapore Pte Ltd OrbusNeich Medical Pte Ltd MINVASYS Lepu Medical Technology (Beijing) Co., Ltd Eurocor Pie Medical Imaging MEDTRONIC INTERNATIONAL, Ltd CID SpA INNOHEART PTE LTD NATIONAL HEART CENTRE SINGAPORE Final Programme / 12th-14th January, 2012 / Singapore 38